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Abstract
Peptoids are peptidomimetic oligomers that predominantly harness similarities to peptides
for biomimetic functionality. The incorporation of chiral, aromatic side chains in the peptoid
sequence allows for the formation of distinct secondary structures and self-assembly into
supramolecular assemblies, including microspheres. Peptoid microspheres can be coated onto
substrates for potential use in biosensor technologies, tissue engineering platforms, and drugdelivery systems. They have potential for use in biomedical applications due to their resistance to
proteolytic degradation and low immunogenicity. This dissertation focuses on the physical
characteristics and robustness of the peptoid microsphere coatings in various physiological
conditions, along with their ability to serve as ELISA microarray and tissue engineering
substrates. We have shown that the peptoid microspheres are suitable substrates for layer-bylayer technologies to create biomimetic artificial extracellular matrices for tissue engineering.
Overall, this study demonstrates that peptoid microsphere coatings are suitable materials for
many biological applications.
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1.

Introduction
Biomaterial research is an exciting field that has grown steadily over the last several

decades. Biomaterials are made of either synthetic or natural components that are with biological
systems [1]. They are typically designed to produce a precise reaction with the biological system
for a specific application [2]. In 1987, the term, biocompatibility, was explained as the ability of
a material to perform with an appropriate host response in a specific application [3, 4]. More
specifically, the material does not induce undesirable responses and is not toxic, while also
promoting the functionality of the device for its application [4].
Progress in biomaterial design and engineering has enabled novel biomaterials to be
prime candidates for applications in biosensing [5], tissue regeneration [6], and drug delivery
systems [7]. Each specific application has guidelines for the biomaterial designation. For
instance, drug delivery materials must allow for the controlled and targeted delivery of drugs
without causing an unwanted immune response [8]. Therefore, it is important to create
biomaterials with ideal properties and biocompatibility for the desired application.
1.1

Types of Biomaterials
Biomaterials can be divided into different material classes, including metals, ceramics,

polymers, and composites [9]. Each type of material has unique surface chemistries and
compositions that dictate their biological functionality. These properties can be tuned to have a
desired effect on the biological response and outcome [10]. Metals are often used as medical
implants in various parts of the body due to their inertness and excellent mechanical properties
that prevent wear and fatigue of the material. Generally, the metal materials must be coated with
a biopolymer to promote bio-functionality, such as blood compatibility and bioactivity necessary
for successful implantation [11]. Ceramics, like metals, are commonly used as implants and for
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the repair of damaged body parts. Alumina and zirconia are bio-inert ceramics, while calcium
phosphates and glass-ceramics are considered bio-active ceramics. Both classes are used for the
repair of diseased parts of the body by mimicking the natural calcified tissue [12]. Although
useful as implants, metal and ceramic biomaterials are limited in other applications due to their
difficult and expensive manufacturing process, and their lack of bio-functionality [11, 12].
1.2

Biopolymers
Biopolymers are chained molecules that are produced from living matter. The monomer

units of biopolymers typically consist of amino acids for proteins/peptides, saccharides for
sugars, or nucleotides for nucleic acids [13]. Peptides, specifically, are used in a variety of
biomedical applications such as treatment for type 2 diabetes, prostate cancer, anemia, and many
other diseases [14]. Peptides make excellent biotherapeutic and biomaterial candidates due to
their good safety, efficacy, and high selectivity [15]. However, they are relatively chemically
unstable due to the ease of proteolytic degradation in vivo causing their half-lives to be
drastically reduced [16]. Proteins and peptides are also prone to aggregation, which can directly
reduce their function and activity [17]. Synthetic peptides are of great interested because of their
ease of synthesis and ability to mimic peptide sequences utilized in nature. They possess many of
the advantages as natural peptides (e.g. biocompatibility, bioavailability, low toxicity), but are
also prone to degradation when exposed to proteolytic enzymes [18, 19].
The disadvantages of peptides have led researchers to pivot to new classes of non-natural
polymers, called peptidomimetics, that are designed to mimic the function of natural peptides
[16, 20]. These polymers often mimic the secondary and tertiary structure of peptides, but small
structural differences result in more protease resistant molecules [21]. Examples of these
molecules includes β-peptides and poly-N-substituted glycines (peptoids) [21, 22, 23]. These
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compounds have shown excellent bioavailability and the ease of synthesis makes them ideal
candidates for many biomedical applications.
1.3
1.3.1

Applications for Biopolymers
Drug Delivery Systems
Although many biotherapeutic drugs have proven successful as treatment options for

various diseases, there are still complications with delivery. Traditional routes, including oral,
sub mucosal (nasal), parenteral (injection), and transdermal (through the skin) [24], are not
feasible due to enzymatic degradation and low absorption efficiency [25]. The oral delivery of
biotherapeutic proteins faces issues with poor absorbance within the gastrointestinal system and
chemical degradation due to harsh enzymes within the digestive system, resulting in the loss of
activity and function [26]. These pH-sensitive drugs are prone to degradation within the colon’s
harsh environment [27]. Subcutaneous injections and transdermal administration routes are
challenging due to immunogenic potential and unwanted immune responses [28]. It has been
reported that subcutaneous degradation occurs with protein-based drugs due to the lymphatic
transfer of these proteins when delivered parenterally [29]. Nasal drug delivery is of interest due
to the high vascularity and permeability within the nasal mucosa [30, 31]. As seen with other
delivery methods, the body’s immune defense mechanism bodes an even bigger issue. If the
biotherapeutic causes any irritation in the nasal mucosa, then the mucocillary clearance
mechanism will cause the drug to be rapidly diluted, increasing the clearance by forming nasal
mucus that will be eliminated from the nose [32]. For this reason, drug delivery systems are
growing in interest to combat the immunogenicity issues of protein therapeutics.
Drug delivery systems help facilitate the successful delivery of a drug candidate to
specific body sites. Currently, most drug delivery systems are within the colloidal size range (1-
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1000nm), and act to release the drug at a controlled rate for a prolonged period of time [33]. The
drug is typically kept within a solid inner matrix that is layered by a permeable outer polymeric
membrane through which the drug diffuses [34].
Focus has been on biopolymer drug delivery systems created from both synthetic and
natural polymers, such as polylactic-co-glycolic acid (PLGA) nanoparticles and lipid-based
carriers, respectively. PLGA nanoparticles are attractive for drug delivery due to their
biodegradability and biocompatibility, FDA approval in parenteral administration systems, welldescribed production and characterization methods, protections from drug degradation, sustained
release capabilities, possibility to modify surface properties, and target specificity for desired
organs or cells [35]. Despite these desirable properties, PLGA-nanoparticles have their
limitations when dealing with certain biotherapeutics such as peptides and proteins. The
synthesis process of these nanoparticles involves factors and processes that may cause the
protein to become aggregated and denatured [36]. Another issue associated with the use of
nanoparticles is the complexity of cellular uptake and the unknown stability and cytotoxicity of
the nanoparticles following metabolism [37, 38]. Liposomes and lipid-based carriers have
already had a major impact on targeted therapeutic protein delivery. Liposomes are defined as
phospholipid vesicles consisting of multiple lipid bilayers enclosing discrete aqueous spaces
[39]. Liposomes and lipid-based carriers are advantageous as drug delivery systems due to their
biocompatibility, ability to self-assemble, extended drug circulation time, and their ability to
carry multiple drugs at once [40]. However, as with other drug delivery systems, lipid-carriers
are still susceptible to enzyme degradation, primarily in the spleen and liver [41].
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Therefore, it is necessary to create a robust drug delivery system that better protects the
therapeutic drug from enzymatic degradation, while also promoting the selective release at the
target location.
1.3.2

Disease Detection
The overall knowledge and treatment options for various types of cancers has drastically

increased over the past several decades. Although there is much optimism within the cancer
biology field, as seen by increased cancer survival rates, there is still plenty of work to be done
towards diagnostic tools. Diagnosis of a disease typically follows the first sign of symptoms,
which in many cancers, is considerably too late. There is a direct correlation between mortality
rates and disease progression [42]. If caught early, many forms of cancer and other diseases can
be treated effectively. However, early stages of cancer are often asymptomatic, and diagnosis
relies on the observation of tumor growth. The National Cancer Institute’s SEER Program
studied this correlation and showed that the 5 year survival rate in skin cancer (92%) and breast
cancer (89%) were must higher than those for internal organs, such as lung cancer (21%) and
pancreatic cancer (10%) [43]. The most common diagnostic techniques include taking a biopsy
of the tumor site or performing imaging techniques (e.g. CT scan, MRI, ultrasound, nuclear scan,
or PET scan) [44]. Unfortunately, these techniques do not provide a platform for early detection
due to the tumor already being present.
The early detection of disease reduces the economic burden by decreasing the amount
and extensiveness of treatments, while also decreasing the mortality associated with the disease
[45]. Ideal diagnostic technologies would be able to detect molecular changes present in
asymptomatic populations during the onset of disease with high specificity. Researchers have
focused their efforts on developing biomarker-based technologies due to their sensitivity and
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ability to provide information on the state of a biological process [46]. Cancer biomarkers can
display the genotoxicity, hyperproliferation, hyperplasia, inflammation, mutations, altered
patterns of gene and protein expression, promoter methylation, and enzymatic changes that occur
in response to disease [46, 47]. Protein-based biomarkers provide a natural platform that relies on
the identification of altered protein expression levels in disease states [48, 49]. To detect and
quantify the protein levels, researchers have looked at antibody-based arrays because of their
high target specificity [50]. Unfortunately, the approval rate for these biomarkers is hampered by
the molecular heterogeneity for various populations of tumor tissues.
Enzyme-linked immunosorbent assay (ELISA) microarray technology was developed in
the early 2000’s [51, 52] for the purpose of analyzing numerous biomarkers in parallel with
higher sensitivity than traditional immunoassays [53, 54]. It is considered a low-cost and
efficient screening technology that uses small volumes of clinical samples and expensive
antibodies to test multiple proteins at the same time, also known as multiplex [55]. The design of
ELISA microarray involves the immobilization of small amounts of antibodies onto a solid
support in an ordered pattern, a microarray [52]. The antibodies bind protein analytes onto the
surface, in which the microarrays are then incubated with the clinical sample and tagged for
fluorescent detection.
The challenge to ELISA microarray and other protein/antibody microarrays is producing
a slide surface that promotes strong antibody attachment, without disrupting the high binding
capacities, signal-to-noise ratios, and reproducibility. These surface structures also have to be
robust enough to retain high specificity and sensitivity levels through rigorous processing
conditions and prolonged storage periods [56, 57]. These microarray surfaces are typically
defined as either two-dimensional or three-dimensional surfaces. Glass slides are frequently used
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for two-dimensional solid support platforms, where they must be functionalized with various
chemicals (e.g. aldehyde, aminosilane, epoxysilane, mercaptosilane, polystyrene, and poly-Llysine) to promote antibody attachment [58]. The covalent attachment of antibodies to twodimensional surfaces results in strong attachment, but the close contact with the surface can
affect the protein structure and function [59].
Three-dimensional surfaces immobilize proteins through physical adsorption from the
hydrophobic interactions within their structures. This results in the proteins maintaining their
native structure forming a more optimal surface with increased binding capacities and signal
intensities [60]. In theory, increasing the surface area by using three-dimensional substrates for
antibody attachment should enhance the microarray results by providing more sites of attachment
to increase signal intensity and the dynamic range. Polymer-based surfaces that increase surface
area such as polyacrylamide [47, 61], agarose [62], and nitrocellulose [63] suffer from low
signal-to-noise ratios due to absorption of protein in the porous coating [64].
1.3.3

Tissue Engineering
According to an American Heart Association study in 2015, there are nearly 800,000

persons in the United States that suffer from stroke and over 140,000 die each year. Strokes are
the fifth leading cause of death and considered the leading cause for serious long-term disability
[65]. A stroke occurs when blood is restricted from the brain by either a blood clot (ischemic) or
ruptured blood vessel (hemorrhagic) causing irreversible damage through the formation of
cavities, or areas of dead brain tissue [66]. Current treatment options are limited to surgically
repairing the ruptured blood vessel or using tissue plasminogen activator (tPA) to break up the
clot. However, these treatments hold much risk due to the invasiveness and potential for
infection that surgery poses, as well as the fact that tPA is only successful if used within the first
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few hours from the onset of symptoms [67]. Often the patients are left with lifelong impairments
in their motor function and lose the ability to complete routine tasks such as reading, writing, and
talking.
In order to combat central nervous system (CNS) damage it’s important to gain a better
understanding of the self-renewal ability and neurogenesis of neuronal stem cells. Past evidence
has shown that human neurons naturally undergo neurogenesis within two areas of the brain: the
hippocampal dentate gyrus and the anterior subventricular zone [68, 69]. Self-renewal of these
cells is often limited to low amounts of healthy neurons that decrease with age and severity of
brain injury [70]. The mechanism of neurogenesis is of interest within the regenerative biology
and tissue engineering fields where healthy neuronal cells, molecules, and supporting structures
are implanted into diseased tissue to promote neuron regeneration [71, 72]. The ability of
embryonic stem cells (ESCs) and human mesenchymal stem cells (hMSCs) to grow and
differentiate into multiple cells types, especially neuronal cells, make them an interesting
candidate for stroke, traumatic brain injury, and PNS injury treatment [73, 74].
Human embryonic stem cells are multipotent cells derived from the undifferentiated germ
layers found in early developing embryos, called blastocysts [75]. Mesenchymal stem cells are
easily isolated from adult bone marrow tissue and, like hESCs, are multipotent and possess selfrenewable properties [76]. Both cell types can be directed to differentiate into specific adult cell
lineages depending on the cellular microenvironment for various cell therapy applications. To be
a viable tissue regeneration option there needs to be a better understanding in the differentiation
pathways and what role the environment plays in dictating the stem cell fate.
The extracellular matrix (ECM) is a three-dimensional network composed of proteins and
macromolecules that physically support surrounding cells [77]. The ECM’s biochemical
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composition and surface play a major role in stem cells’ ability to grow and differentiate into
adult cell types [78]. The topography and spatial arrangement of features on artificial ECM
surfaces has shown to guide stem cell attachment and differentiation into specific adult cell types
[79]. Current artificial ECM materials are made from either natural or synthetic components.
Natural components include both proteins (laminin, collagen, fibronectin, etc) and carbohydrates,
primarily glycosaminoglycans (heparin, chondroitin sulfate, and hyaluronic acid) and
polysaccharides (chitosan and cellulose) [80]. Although suitable, these materials are often
difficult to isolate and purify making them expensive to culture cells in large quantities. Along
with the cost, the natural materials can be easily degraded when exposed to cellular conditions
for extended periods of time and are limited to two-dimensional networks [81].
Synthetic components typically consist of nanomaterials, hydrogels, membranes, and nonnatural polymers. The advantages to using synthetic ECM mimics is that they are more
consistent and customizable than naturally derived materials. There is less batch-to-batch
variability and the chemistry and mechanical properties can be tuned to suit an individual
application [82]. For years, polyglycolic acid (PGA), poly(L-Lactic acid) (PLLA), poly)lacticco-glycolic acid) (PLGA), poly(anhydrides), and poly(orthoesters) have been used to fabricate
synthetic ECMs [83]. These polymers possess excellent biocompatibility, the degradation rate
can be tailored, and they can easily be molded and cast into desired shapes and sizes [84]. Most
synthetic ECM materials do not directly mimic the in vivo cell environment and lack critical
biomolecular signaling dynamics [85]. There is a need for a material that directly mimics the
three-dimensional substrates found in neuronal networks to gain a better understanding of the
effect of topographical cues on neuronal stem cell fate.
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1.4

Peptoids (Poly-N-Substituted Glycines)
Naturally occurring peptides possess excellent biological properties that theoretically make

them ideal candidates for biomedical applications. However, due to their susceptibility to in vivo
proteolytic degradation they are actually limited in their functionality. Research efforts have
focused on creating peptidomimetics, non-natural polymers that are designed to directly mimic
peptides. Peptidomimetics are structurally and functionally similar to peptides but have improved
stability against proteolysis and increased bioavailability [86]. Peptides often utilize their ability
to assemble into complex three-dimensional secondary and tertiary structures. In order to mimic
these advanced structures of peptides, specific peptidomimetics, called foldamers, also display
well-defined secondary and tertiary structures [21].
Peptoids, or N-substituted glycines, are synthetic peptidomimetic oligomers that structurally
resemble α-peptides but have side chains attached to the amide groups on the backbone instead
of the α-carbon as in peptides (Figure 1.1) [23]. This structural modification generates an achiral
backbone that eliminates the potential for hydrogen bonding, resulting in a protease-resistant
polymer that exhibits good cell computability and protein binding characteristics resembling that
of more “drug-like” molecules [87]. The small size and protease-resistance also makes peptoids
biocompatible as they are unlikely to illicit an immune response.
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Figure 1.1 Comparison of peptide and peptoid structures.
1.4.1

Peptoid Synthesis

The ease and efficiency of peptoid synthesis makes them an attractive peptidomimetic
polymer. Peptoids can be produced via a sequence-specific, solid-phase synthesis method
comparable to that of peptides [89]. Unlike peptide synthesis, where submonomers must be
protected prior to addition, peptoid synthesis allows for the precise addition of unprotected
submonomers greatly simplifying the process. The submonomer method is a highly efficient, low
cost synthesis technique that allows for the addition of a wide variety of side chains as primary
amines [89].
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Figure 1.2 Illustration of peptoid submonomer solid-phase synthesis process [99].

Using a solid-phase support (ex: rink amide resin), submonomers are added from carboxylic
to amine termini via a submonomer “cycle” made up of two-steps: (1) acylation and (2)
amination (nucleophilic substitution) (Figure 1.2) [89]. The first reaction of the submonomer
cycle, acylation, adds an activated carboxylic acid derivative onto a receptive amine generating a
tertiary amide bond. In general, bromoacetic acid (BAA) and diisopropylcarbodiimide (DIC) are
used for acylation. The BAA is activated by DIC separately, and then added to the solid-phase
support [89]. The second step in the cycle, amination, involves the nucleophilic displacement of
the halide (typically bromine) by a primary or N-terminal secondary amine (side chain). As the
halide group is removed from the haloacetamide, the primary nitrogen submonomer attacks the
alpha-carbon forming an ammonium salt. The halide ion then removes hydrogen from the
ammonium salt producing hydrogen bromide. The amination step creates the molecular diversity
that is present in peptoids due to the thousands of commercially available amine side-chains.
Once synthesized, the peptoid molecule is cleaved from the resin and purified using preparative
high-performance liquid chromatography.
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1.4.2

Peptoid Microspheres

The backbone modification in peptoids eliminates the potential for hydrogen bonding, which
is critical for secondary structure formation in peptides. However, including chiral side chains
can induce secondary structures in peptoids such as turns, loops, and helices that allow for the
formation of supramolecular assemblies [90, 21]. Peptoid helices are extremely robust as they
are stabilized by steric hindrance and electrostatic repulsions between the side chains [90].
Peptoid homooligomers of (S)-methylbenzylamine as short as five monomers have shown
polyproline type-I-like helices confirmed by circular dichroism (CD). The presence of minima at
207 nm and 2011 nm and a maximum at 190 nm resemble the spectrum for a peptide α-helix
[92].
The Servoss lab has demonstrated that helical peptoids with partial water solubility selfassemble into microspheres in solution and can be cast onto a solid surface to form coatings. The
peptoid of interest, P3, contains chiral, aromatic side chains that are positioned on two faces of
the helix (Figure 3) to induce secondary structure and ultimately form microspheres
(supramolecular structure) (Figure 4). The third face of the helix contains positively charged
lysine-like side chains to enhance binding onto various substrates and incorporation of other
adducts. The peptoid sequence and the effect that side chain placement (charge and bulk) along
with the partial water solubility and helical content have been studied in detail [92, 93, 94].
Dissolving the peptoid in a 4:1 alcohol to water solution enables the formation of microspheres
that can optimally be coated onto glass substrates. Further work has investigated the factors that
affect the reproducible nature of microsphere coating formation including solvent effects,
administration techniques, and drying conditions. These studies have shown that a 4:1 solution of
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ethanol: water, drop-coating, and drying at 55% humidity produces optimal coatings that have
excellent microsphere coverage.
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Figure 1.3 Structure of P3 peptoid (MW=1919 Da).

Figure 1.4 Schematic representation of peptoid microsphere formation [93].
The peptoid microsphere coatings have excellent potential as drug delivery agents,
biosensors, and artificial extracellular matrices. They are advantageous for the applications due
to their topographical features, biocompatibility, and customizability. The spatial arrangement
and contact angle of the microsphere coatings can be tuned for desired topographical properties.
The positive surface charge of the microspheres can also be utilized in adding natural ECM
components, such as laminin, collagen, heparin, and fibronectin, through polyelectrolyte
multilayers.
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1.5

Polyelectrolyte Multilayers
Polyelectrolyte coatings are rapidly gaining interest as biomaterials for various medical and

pharmacology applications due to their ease and versatility [95]. Layer by layer (LbL) formation
of polyelectrolyte multilayers (PEMs) is an intriguing method for surface modifications and
nanoscale material synthesis. LbL utilizes the ionic attraction between opposite charges in
alternating the adsorption of anionic and cationic polyelectrolytes [96]. The ability of PEMs to
tune the chemical, physical, and topographical properties simply by altering the pH, ionic
strength, number of layers, and layer thickness makes them ideal candidates for aECM substrates
[97]. PEMs can be assembled by both naturally occurring and synthetic polymers where the
library of potential polymers is endless. For example, PEMs constructed from naturally occurring
polymers, heparin and collagen doped with IFN-γ, were able to promote enhanced cellular
behaviors in human mesenchymal stem cells [98]. The tunability of PEM films make them
interesting candidates as aECM substrates for neurogenesis in tissue engineering applications.
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2.

Research Rationale
This dissertation is focused on developing and characterizing peptoid microspheres (Chapter

3) as suitable substrates for biosensing (Chapter 4), LbL fabrication (Chapter 5), and tissue
engineering applications (Chapter 6). It supports work done by Jesse Roberts and Dr. Shannon
Servoss to assemble a novel, three-dimensional peptoid substrate for biosensing and tissue
engineering applications. The peptoid microspheres provide potential to be a more biocompatible
and customizable substrate than commercially available polymer-based substrates. The peptoid
microspheres possess the ability to attach other naturally occurring biopolymers (laminin,
collagen, heparin, etc.) through polymeric multilayer fabrication methods to combine the
topography and surface chemistry that the stem cells favor.
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3.

Peptoid Microsphere Coatings: The Effects of Helicity, pH, and Ionic Strength

German R. Perez Bakovic, Jesse L. Roberts, Bryce Colford, Myles Joyce, and Shannon L.
Servoss
Ralph E. Martin Department of Chemical Engineering, University of Arkansas Fayetteville
Abstract
Peptoids are peptidomimetic oligomers that predominantly harness similarities to peptides
for biomimetic functionality. They have potential for use in biomedical applications and
biosensors due to resistance to proteolytic degradation and low immunogenicity. The
incorporation of chiral, aromatic side chains in the peptoid sequence allows for the formation of
distinct secondary structures and self-assembly into supramolecular assemblies, including
microspheres. Peptoid microspheres can be coated onto substrates for potential use in biosensor
technologies, tissue engineering platforms, and drug-delivery systems. In order to be useful for
these applications, the peptoid coatings must be robust under physiological conditions. In this
study we report the effects of various conditions on the peptoid microsphere coatings, including
(i) helicity, (ii) temperature (iii) pH, and (iv) ionic strength. These studies show that microsphere
size decreases with increasing peptoid helicity and the positively charged side chains are
positioned on the outside of the microspheres. The peptoid microsphere coatings are robust under
physiological conditions but degrade in acidic conditions (pH < 7) and at low ionic strengths (<
150 µM).
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3.1

Introduction
Natural polymers, such as proteins and peptides, have inspired the development of

synthetic materials that mimic the fundamental molecular features, and are therefore also able to
mimic the function. [1] While proteins and peptides have a myriad of unique functional
properties, as biomaterials they are limited due to proteolytic degradation and as a result are
restricted in their potential for use in biomedical and therapeutic applications. [2] Efforts to
overcome these limitations have led to the design and development of innovative peptidomimetic
oligomers.

[3, 4, 5, 6, 7, 8] These

synthetic oligomer analogs largely exploit structural similarities to

allow for bioactive functionalities. Some bioactive roles are determined by the unique ability of
proteins and peptides to self-assemble into complex, sequence-specific secondary and
supramolecular structures. [9] Specific peptidomimetic oligomers, commonly referred to as
foldamers [10], display well-defined secondary structures, and are therefore of great interest for
use in biomaterials.
One class of foldamers, peptoids or poly-N-substituted glycines, closely resemble
peptides, with the side chains attached to the backbone amide nitrogen rather than the backbone
α-carbon as in peptides. This seemingly minor modification to the backbone has important
implications to peptoid structure and function, including reduced proteolytic degradation that
makes them a promising alternative to peptides for therapeutic applications where proteolysis is
of major concern. The backbone modification also prevents hydrogen bonding within the
backbone, which is critical for the formation of secondary structure in peptides. However,
including specific side chains can induce the formation of peptoid secondary structures such as
turns [11, 12], loops [13], and helices [14, 15, 16, 17, 18] that allow for the formation of supramolecular
assemblies.

[19, 20, 21, 22, 23, 24] For peptoid

homooligomers of (S)-methylbenzylamine, stable helices
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are formed with as few as five monomer units and full helicity is reached at 13 monomer units. [9]
The circular dichroism (CD) spectra strongly resembles that for protein α-helices [9] and NMR
confirms a helical structure similar to protein polyproline type-I helices, with a periodicity of
three residues per turn and a helical pitch of ~6 Å. [16] Like peptides, peptoids are constructed via
solid-phase synthesis, but following a submonomer method that provides a robust and highly
efficient synthesis platform with precise sequence control. [25] Side chains are introduced by the
incorporation of commercially available primary amines, enabling access to more than 300 side
chain chemistries. [1]
Previous work has focused on the effects of peptoid water solubility, helical content,
charge placement, and side chain bulk on self-assembly into microspheres.

[24]

Both peptoid

helicity and partial water solubility were found to be crucial for microsphere formation. The
microspheres (0.3 – 3.6 µm) are orders of magnitude larger than the length of a single peptoid
helix (~24 Angstrom), suggesting that larger peptoid groupings are formed by stacking of the
chiral aromatic groups. [24] Aromatic stacking has been observed in similar types of
supramolecular assemblies for both peptides and peptoids. [26, 22, 27, 28, 29] Further, peptoid
sequences with alternating positive and negative charges on one face of the helix produce smaller
microspheres (~0.3 μm) as compared to those with alternating positive and neutral charges on
one face of the helix (~1.5 μm). It is believed that the opposite charges interact to form tighter
helices, resulting in smaller microspheres.

[24]

Further work in the Servoss lab investigated the

factors that affect the reproducible formation of microsphere coatings including solvent effects,
administration technique, and drying conditions. [30] These studies showed that reproducible
coatings were formed by solubilizing the peptoid in an aqueous solution of protic solvent,
completely covering the surface with solution, and allowing it to dry at room temperature with
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60% humidity.
Potential applications for peptoid microspheres include biosensors, artificial extracellular
matrices, and drug delivery systems. The customizability of the microsphere chemistry allows
for the fine-tuning based on application or environment. The work reported here shows the effect
of peptoid length (and in turn helicity) on microsphere size, as well as the effects of temperature,
pH, and ionic strength on the robustness of peptoid microsphere coatings. The surface charge and
phase transition temperatures of the different peptoid lengths were measured using zeta potential
and differential scanning calorimetry (DSC), respectively. Scanning electron microscopy (SEM)
and ImageJ processing show that as peptoid chain length, or helicity, is increased microsphere
size decreases and the size distribution increases. Zeta potential proved that there is a positive
charge located on the outer surface of the peptoid microspheres, and DSC showed that the
melting temperatures ranged from 78-83°C for the various peptoid lengths. Furthermore, SEM
confirmed that the microsphere coatings are extremely robust under physiological conditions,
however they degraded in low ionic strength and low pH solutions.
3.2

Materials and Method

3.2.1

Materials
(S)-methylbenzylamine and 4-methoxybenzylamine were purchased from Acros

Organics (Pittsburgh, PA). tert-butyl N-(4-aminobutyl)carbamate was purchased from CNH
Technologies Inc. (Woburn, MA). MBHA rink amide resin was purchased from NovaBiochem
(Gibbstown, NJ). Piperidine was purchased from Sigma-Aldrich (St. Louis, MO). Ultra clean
glass microarray slides, and disuccinimidyl suberate (DSS) were purchased from Thermo
Scientific (Pittsburgh, PA). All other reagents were purchased from VWR (Radnor, PA). All
chemicals were used without further modifications unless otherwise specified.
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3.2.2

Peptoid Synthesis, Purification, and Characterization
Peptoids were synthesized following a submonomer, solid-phase method on rink amide

resin, as previously described. [25, 31] Synthesis follows a carboxy to amino direction and the
submonomer method includes two steps: acylation to extend the backbone and nucleophilic
substitution to incorporate the side chain. [32] Briefly, the resin was swelled with
dimethylformamide (DMF), and the Fmoc protecting group was removed using a 20% solution
of piperidine in DMF. The resin-bound secondary amine was acylated with 0.4 M bromoacetic
acid in DMF in the presence of N,N’-diisopropyl carbodiimide, mixing for 1 minute. Amine
submonomers were incorporated via an SN2 nucleophilic substitution reaction with 0.5 M
primary amine in DMF, mixing for 2 minutes. The two-step acylation and nucleophilic
substitution cycle was repeated until the desired sequence was obtained. The peptoid was cleaved
from the resin using a mixture of 95% trifluoroacetic acid (TFA), 2.5% water, and 2.5%
triisopropylsilane.
Peptoids were purified using a Waters Delta 600 preparative high-performance liquid
chromatography (HPLC) instrument (Milford, MA) with a Duragel G C18 150 × 20 mm column
(Peeke Scientific, Novato, CA) and a linear gradient of 35-95% solvent B (acetonitrile, 5%
water, 0.1% TFA) in A (water, 5% acetonitrile, 0.1% TFA), over 60 minutes. Peptoids were
confirmed to be >98% pure via analytical HPLC (Waters Alliance) with a Duragel G C18 150 ×
2.1 mm column (Peeke Scientific) using a linear gradient of 35-95% solvent D (acetonitrile,
0.1% TFA) in C (water, 0.1% TFA), over 30 minutes. Presence of the desired sequence was
confirmed via matrix assisted laser desorption/ionization time of flight (MALDI-TOF) mass
spectrometry (Bruker, Billerica, MA). Purified peptoid fractions were lyophilized and stored as a
powder at -20 °C.
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3.2.3

Circular Dichroism
Peptoid secondary structure was confirmed via circular dichroism (CD) spectroscopy

using a Jasco J-715 instrument (Easton, MD). The peptoids were dissolved in methanol at a
concentration of 60 µM. Data was collected at room temperature with a scanning speed of 20
nm/min in a cuvette with a path length of 0.2 mm. Each spectrum was the average of twenty
accumulations.
3.2.4

Peptoid Microsphere Coatings
Peptoid microspheres were prepared by dissolving the peptoid in a 4:1 ethanol/water

(v/v) solution at a concentration of 5 mg/mL. The peptoid solution was applied to glass
substrates using a pipette and allowed to dry at room temperature and 60% relative humidity for
one hour. Coating morphology was imaged using a Phillips XL-30 environmental scanning
electron microscope (SEM; FEI, Hillsboro, OR).
3.2.5

Microsphere Size Analysis
Particle size analysis was performed using ImageJ software (National Institute of Health,

MD). Noise reduction was completed with a fast Fourier transform (FFT) band-pass filter
normalization, eliminating low- and high-spatial frequencies and transforming the original SEM
images to a two-dimensional representation of the frequency. The images were converted to 8-bit
grayscale and binarized adjusting the white and black threshold to optimize particle contrast with
the background. Greater than 200 particles were manually evaluated for each experimental
condition and plotted using Origin2018.
3.2.6

Surface Charge Measurements
The surface charge of the peptoid microspheres was measured in terms of zeta potential

using a Beckman Coulter Delsa NanoHC instrument (Brea, CA). A flat cell was employed for
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determination of the zeta potential of the peptoid microspheres. The peptoid microsphere
coatings were submerged in the feed solution that was set at a neutral pH of 7.0 and the
measurements were taken.
3.2.7

Differential Scanning Calorimetry
The melting temperature and phase transition properties of the peptoid microspheres were

measured using a TA Instruments Differential Scanning Calorimeter Model 25 (New Castle,
DE). The peptoid microspheres were formed by dissolving peptoid in a 4:1 ethanol/water (v/v)
solution at a concentration of 3 mg/mL. The peptoid microspheres were deposited onto a TA
Instruments Tzero aluminum pan at a constant volume of 60 µL. The pan was set in a holding
vessel where a lid was hermetically sealed using a specialized Tzero Press. Individual sample
masses were taken and documented in the DSC control software, TRIOS v4.4, where after
temperature equilibration at 0 °C, an isothermal period of ten minutes was completed. The
ramping period of 20 °C per minute up to a maximum temperature of 200-240 °C was used to
determine the phase transition and melting temperature of the peptoid microspheres. Upon
conclusion, the plot of normalized heat flow (W/g) versus temperature (°C) was analyzed and the
peak integration function within TRIOS resulted in the normalized enthalpy (J/g) and peak
temperature (°C) for phase change.
3.2.8

Coating Robustness Under Biological Assay Conditions
The robustness of the peptoid microsphere coatings was assessed by incubation in

solutions common to bioanalytical assays that have various values of pH and ionic strengths.
Specifically, the coatings were incubated in 10 mg/mL casein in phosphate-buffered saline (PBS;
pH 7.3, ionic strength 150 mM) for one hour, 0.05% Tween in PBS (PBS-T; pH 7.3, ionic
strength 150 mM) for 12 hours, 0.003% hydrogen peroxide in 0.1M sodium borate (pH 8.2, ionic
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strength 600 mM) for 10 minutes, and nanopure water (pH ~7, ionic strength ~0 mM) for up to
30 minutes.
3.2.9

Effect of Temperature, pH, and Ionic Strength on Coating

The ability of the peptoid microsphere coatings to withstand temperature, pH, and ionic
strength was assessed through incubation in various solutions. The effect of temperature was
evaluated by incubating the peptoid microsphere coatings in PBS and water at 37 °C. The
temperature of both PBS and nanopure water was preheated and kept constant at 37 °C using a
covered incubation chamber and hot plate. The pH and ionic strength robustness studies were
assessed by incubating the peptoid microsphere coatings in solutions ranging from pH 3-11 and
ionic strength of 0-500 mM at room temperature (25°C). The solution pH was adjusted by
adding a stock hydrochloric acid or sodium hydroxide solution drop-wise until the desired pH
was attained. The coatings were incubated in solutions of different pH values (pH = 3, 4, 5, 6, 7,
8, 9, 10, 11) for one hour. The ionic strength of water and PBS was adjusted using a stock
potassium chloride solution until the desired ionic strengths were obtained. The coatings were
incubated in solutions of different ionic strength values (ionic strength = 0, 50, 100, 150, 250,
500 mM) for one hour. The robustness of the peptoid microsphere coatings was assessed via
SEM by analyzing microsphere morphology and surface coverage.
3.3

Results

3.3.1

Peptoid Sequence and Characterization
The peptoid sequences used in this study (Figure 3.1A) are based on that of a helical and

partially water soluble 12mer that was previously reported to form microspheres.

[24]

Helical

secondary structure is induced by including two-thirds chiral, aromatic side chains (Nspe) such
that two faces of the helix contain Nspe side chains (Figure 3.1B). This configuration allows for
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interactions between the benzene rings on different peptoid molecules. The third face of the
peptoid helix contains alternating side chains with amine and methoxybenzyl groups to increase
water solubility, as well as facilitate attachment to glass substrates. In this study, the length of the
peptoid was varied by repeating the same six monomer unit for final lengths of 6, 12, 18, and 24
monomers (Figure 3.1A).

Figure 3.1 (A) Linear peptoid sequence. Four peptoids were studied: 6mer (n=1, MW=968),
12mer (n=2, MW=1919), 18mer (n=3, MW=2870), and 24mer (n=4, MW=3821). (B)
Representation of the 12mer peptoid helix.
Peptoid helicity was assessed by CD spectroscopy (Figure 3.2). The 12mer, 18mer, and
24mer peptoids exhibit a maximum near 193 nm and two minima near 208 and 222 nm,
indicative of polyproline type-I-like peptoid helices. [32] The 6mer also displayed a maximum
near 193 nm and a minima near 222 nm; however, a second minima at 200 nm indicates both
random coil and polyproline type-I-like peptoid helix secondary structures. [33] The relative
helicity increases with peptoid length, as evidenced by the increasing intensity of the minimum
peak at 222 nm. [34] This corresponds to previous studies, which have shown that peptoid helicity
increases with peptoid length. [9] This is further corroborated by molecular simulations. [35] These
studies, which were validated by NMR experiments, show that peptoid helix formation is a
function of temperature and chain length; ultimately, proving that as chain length increases
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helicity increases and peptoid helix formation is thermodynamically favorable. [35, 36]

Figure 3.2 Circular dichroism spectra for 6mer, 12mer,
18mer, and 24mer peptoid in methanol at 60 µM.
3.3.2

Effect of Helicity on Microsphere Size and Distribution
It is desirable to tune the size of microspheres for different applications. Based on our

previous results, [30] we hypothesized that peptoids with tighter helicity would form smaller
microspheres. The formation of microspheres by peptoids with different helicities (6mer, 12mer,
18mer, and 24mer) was tested. The peptoids were solubilized in 4:1 ethanol:water and dried on
glass substrates to form the microsphere coatings. Microsphere size was visually assessed by
SEM and measured using ImageJ software. The 6mer peptoid did not form microspheres (Figure
S3.1 in Supplemental Information), likely due to decreased helicity, increased water solubility,
and the limited number of aromatic side chains to induce stacking. The 12mer, 18mer, and 24mer
peptoids all formed microspheres of different sizes (Figures 3.3A, 3.3B, and 3.3C, respectively).
As expected, microsphere diameter decreased with increasing helicity, with average diameters of
2.26 μm, 1.91 μm, and 1.24 μm for the 12mer, 18mer, and 24mer peptoids, respectively.
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The decrease in size is likely due to the increased interactions between the peptoids that
have higher helical content, and therefore closer packing in the microspheres. Conversely,
peptoids with more loose helical structure are not able to pack as tightly and form larger
microspheres. In addition, there is a direct relationship between peptoid length and microsphere
size distribution, with the most uniform size distribution observed for the 12mer peptoid (Figures
3.3A and 3.3D) and the most disperse sizes observed for the 24mer peptoid (Figures 3.3C and
3.3F).
Like the peptoid microspheres, peptide foldamers use their molecular interactions to form
distinct secondary structures that can be tailored into self-assembling supramolecular structures
(spherical micelles [37], worm-like micelles

[38] , lamellar

sheets [39], vesicles [40], nanotubes [41] ,and

fibrils [42]). The size of spherical micelles formed from thermally responsive elastin-like peptides
can be tuned through the secondary structure by altering the total chain length and the
hydrophilic-hydrophobic chain ratio in the peptide. [37] Peptide nanotubes can be formed by
incorporated cyclic peptides with D- and L- amino acids that self-assemble through antiparallel
hydrogen bonding and stereochemical interactions of the peptide backbone. [43] By strategically
assembling the peptide entities at specific ratios and altering the number of amino acids, the
overall length and size of the peptide nanotube can be controlled for desirable end-product
formation. [44] These supramolecular structures prove that the overall size is a function of
secondary structure and intermolecular interactions, like the helicity of the peptoid microspheres.
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Figure 3.3 SEM images of (A) 12mer, (B) 18mer, and (C) 24mer peptoid microspheres. The
size distribution for (D) 12mer, (E) 18mer, and (F) 24mer was evaluated using ImageJ
software.
3.3.3

Surface Charge of Peptoid Microspheres
The surface charge, or zeta potential, of the different length peptoids was obtained using

electrophoretic light scattering (ELS). The zeta potential gives the potential difference between
the solid-liquid interface of the charged particle and the liquid media. It is hypothesized that the
positively charged side chains are located on the outside of the microspheres due to the stacking
of the aromatic groups, as well as the ability of the peptoid microspheres to robustly attach glass
surfaces that have a relative negative charge. The surface zeta potential of the peptoid
microspheres showed a drastic increase as compared to the ultraclean glass (Figure 3.4). The
difference between the unmodified surface and peptoid-coated substrate indicates that the surface
of the peptoid microspheres are positively charged. Although aqueous feed at neutral pH was
used (~7.0), the amine side chain can be protonated (-NH3 +) resulting in a net positive charge. [45]
An increase in zeta potential as the peptoid chain length increases (12mer = +11.85, 18mer =
+28.79, 24mer = +41.64) is potentially due to an increase in the number of cationic side chains,
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along with the increase in the total number of spheres on the substrate that forms from the tighter
helicity.
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Figure 3.4 Zeta potential measurements for control (4:1 ethanol:water),
12mer, 18mer, and 24mer peptoid microsphere coatings.
3.3.4

Differential Scanning Calorimetry Measurements
The thermal behavior of the peptoid microspheres was examined by differential scanning

calorimetry (DSC) to measure the excess heat capacity as a function of temperature. DSC was
run in solid state for the 12mer, 18mer, and 24mer peptoid microspheres to determine the
thermodynamic properties of thermally induced phase transitions such as melting temperature
(Tm), enthalpy in terms of endothermic vs. exothermic peptoid degradation, and the polymorphic
nature of the material. As expected, the heat flow was negative for all three peptoid samples,
suggesting that the peptoid microsphere degradation occurs endothermically as the peptoid
microspheres require heat to break the interactions and bonds during phase transition. [46, 47] The
phase transition temperature increases as peptoid chain length increases, indicating a correlation
between peptoid helicity and thermal stability (Figure 3.5). The 24mer peptoid microspheres had
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the highest melting temperature on average at 82.94 ± 0.3845 °C, while the 12mer and 18mer
peptoid microspheres were similar at 74.00 ± 4.121 °C and 75.22 ± 4.121 °C, respectively. The
broadness in the DSC peaks indicate that the samples are forming polymorphic structures,
similar to many common polymers and other microspheres, and at the melting temperature, over
50% of the sample has undergone a phase transition. [48, 49]
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Figure 3.5 Differential Scanning Calorimetry measurements for control (4:1
ethanol:water), 12mer, 18mer, and 24mer peptoid microsphere coatings.
3.3.5

Coating Robustness under Biological Assay Conditions
In order to be practical in biomedical applications, the 12mer peptoid microsphere

coatings must be robust under various conditions. It was previously observed that the
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microsphere coatings degrade when exposed to ultrapure water for 24 hours [30], therefore a
thorough investigation was completed to determine whether pH, ionic concentration, or a
combination of the two were responsible. The robustness of 12mer peptoid microsphere coatings
was assessed by incubating the coatings in solutions with varying values of pH and ionic
strength, including casein in PBS for 1 hour, 0.05% Tween in PBS for 12 hours, 0.003%
hydrogen peroxide in 0.1M sodium borate for 10 minutes, and nanopure water for 10 minutes.
The microsphere coatings showed minimum degradation, as assessed by morphology and surface
coverage, in all solutions except water (Figure 3.6A-C and Figure S3.2 in Supplemental
Information). After exposure to water for 30 minutes the microspheres appeared to disintegrate
and lift from the surface. Despite the instability of the peptoid microspheres in water, they are
robust in PBS for up to 2 months (Figure S3.3 in Supplemental Information). Based on these
preliminary findings, the effects of pH and ionic strength on peptoid microsphere coating
robustness has been thoroughly investigated.

Figure 3.6 SEM images of the peptoid microspheres coatings (A) before incubation, (B) after
24 hour incubation in PBS, and (C) after 30 minute incubation in water with inset showing a
high magnification peptoid microsphere.

3.3.6

Effect of Temperature on Coating Robustness
The effect of temperature on the 12mer peptoid microsphere coating robustness was

assessed by visually analyzing the coating morphology following incubation in PBS and
nanopure water at a physiological temperature of 37 °C for 30 minutes (Figure 3.7). At this
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temperature, the peptoid microsphere coatings withstood degradation in all solutions except
water. In PBS at 37 °C a small salt layer began forming due to the evaporation and deposition of
PBS salts on the glass substrate, but the overall sphere morphology was maintained. After 30
minutes of incubating in water at 37°C, the microspheres began swelling and lifting from the
surface and overall surface coverage was diminished.

Figure 3.7 SEM images of 12mer peptoid microsphere coatings (A) before incubation (B)
after 30 minute incubation in PBS at 37 °C, and (C) after 30 minute incubation in nanopore
water at 37 °C.
3.3.7

Effect of pH on Coating Robustness
The effect of solvent pH on the 12mer peptoid microsphere coating robustness was

studied by assessment of coating morphology and coverage following incubation in PBS (Figure
3.8) with varying pH. Coatings exposed to solutions with pH of 7 or greater are robust, with no
significant differences in microsphere morphology or coating coverage (Figures 3.8A-8E). As
the solvent starts to approach acidic conditions (pH less than 7), the microsphere morphology
and coating coverage deteriorate (Figures 3.8F-8I). These observations are consistent in both
PBS and water solutions at similar pH values. These studies were confirmed with water-based
solutions (Figure S3.4 in Supplemental Information). While we do not anticipate changes in pH
of the solvent to change the charge state of the peptoids, solubility is increased under acidic
conditions. [50] Peptoids with ionizable side chains have been demonstrated to destabilize in
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response to pH-dependent changes in aqueous solvents. [11, 51] In aqueous solvents, the
supramolecular structure of the peptoid is ultimately determined by interactions between the side
chains and water. In general, polar and charged groups are located on the outside surface due to
their stabilization with water, while the hydrophobic residues tend to favor the inside of the
structure. [52] The charged and polar residues, specifically lysine in the case of the peptoids
studied here, help maintain the solvation necessary to form specific supramolecular structures.
Therefore, at higher pH values the pKa of the lysine-like side chain is stabilized by being
unprotonated or neutrally charged, maintaining an optimal solvation effect allowing the peptoid
microspheres to be robust or less soluble under basic conditions.[53] At low pH (>7) the lysine
side chains are below the isoelectric point resulting in a protonated amine group. The protonation
forms an energetically less favorable charge solvation structure that results in the destabilization
and increased solubility ultimately leading to the deterioration of the peptoid microspheres.

[54]
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Figure 3.8 SEM images of 12mer peptoid microsphere morphology after 30 minutes in PBS
with pH values of (A) 11, (B) 10, (C) 9, (D) 8, (E) 7, (F) 6, (G) 5, (H) 4, or (I) 3.
3.3.8

Effect of Ionic Strength on Coating Robustness
The effect of ionic strength on 12mer peptoid microsphere coating robustness was

visually assessed by SEM following incubation in various ionic strength solutions (0-500 mM) at
pH 6.7 (Figure 3.9). SEM images demonstrate there is no considerable effect on microsphere
morphology at ionic strengths greater than 150 mM (Figures 3.9A-9C). For ionic strength less
than 150 mM, microsphere morphology and coverage showed signs of degradation (Figures
3.9D-9F). Specifically, the microspheres appear to fuse together and detach from the surface at
ionic strengths less than 100 mM.
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Figure 3.9 SEM images demonstrating the effect of ionic strength on sphere morphology
after 30 minutes incubation in water solutions with ionic strengths of (A) 500 mM, (B) 250
mM, (C) 150 mM, (D) 100 mM, (E) 50 mM, and (F) 0 mM.
As compared to peptide helices, peptoid helices are much more stable when under harsh
conditions. As a result, helical peptoids have been demonstrated to be less susceptible to
degradation when exposed to various solvent environments (e.g. 2,2,2-trifluorethanol, methanol,
and concentrated urea) and high temperatures. [18] However, increasing the ionic strength of the
solvent has been demonstrated to stabilize secondary structure for a variety of ionic polypeptides
due to screening the electrostatic repulsion between side chains. [55, 56, 57] Strongly charged helical
peptides are completely destabilized in low ionic strength environments. [58] A similar
dependence has been observed in high-ionic strength solutions for peptoids. [18, 51] It is
hypothesized that the screening of charge-charge repulsive interactions at higher ionic strengths
preserves the helical secondary structure that is crucial for microsphere formation. The
Hofmeister series claims that based on the presence of specific ionic compounds there can be a
salting “in” or “out” effect that changes the hydrophobicity of the solvent composition,
ultimately changing the macromolecules’ optical activity and secondary structure. [59, 60, 61]
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3.4

Conclusion
In this study we have shown for the first time that peptoid relative helicity affects the size of

microspheres formed, the relative charge location on the microspheres, as well as evaluated the
effects of temperature, pH, and ionic strength on the robustness of microsphere coatings. Peptoid
microsphere size can be tuned by varying relative helicity, or peptoid chain length (increased
length leads to increased helicity). Increased relative helicity leads to smaller peptoid
microspheres due to the tight helical secondary structures. Conversely, peptoids with looser
helical structures form larger microspheres. The chain length, related to size, also effects the
surface charge, as increased chain length had a higher surface zeta potential than the shorter
chains. The phase transition temperature for the microsphere coatings increased as the peptoid
chain length increased, pointing towards a stability conundrum between helicity and degradative
resistance. Future studies will be performed to determine the overall number of peptoid
molecules per microsphere, or packing density, using Small Angle X-ray Scattering and Small
Angle Neutron Scattering. These current studies have proven that the peptoid microsphere
coatings are robust at physiological conditions, as well as high pH and ionic strength solutions.
However, under acidic conditions or at low ionic strengths the coatings deteriorate. The ability to
tune peptoid microsphere size, as well as stability at physiological conditions, make peptoid
coatings promising for use in biosensors and other biomedical applications.
3.5

Acknowledgments
We would like to thank Dr. Rohana Liyanage and the Arkansas Statewide Mass

Spectrometry Facility for use of and consultation regarding MALDI, Dr. Mourad Benamara and
the University of Arkansas Electron Optics Facility for use of and consultation regarding SEM,
Dr. Suresh Kumar for use of and consultation regarding CD, Shu-Ting Chen in Dr. Ranil

42

Wickramasinghe’s lab for use of and consultation of zeta potential, and Joshua Tompkins in Dr.
David Huitink’s lab for use of and consultation regarding DSC. Support has been provided in
part by the Arkansas Biosciences Institute, the major research component of the Arkansas
Tobacco Settlement Proceeds Act of 2000. Partial support was provided from the Center for
Advanced Surface Engineering, under the National Science Foundation Grant No. IIA-1457888
and the Arkansas EPSCoR Program, ASSET III.
3.6

References

[1]

T. S. Burkoth, E. Beausoleil, S. Kaur, D. Tang, F. E. Cohen and R. N. Zuckermann,
"Toward The Synthesis of Artificial Proteins," Chemistry & Biology, vol. 9, no. 5, p. 647–
654, 2002.
J. A. Patch and A. E. Barron, "Mimicry Of Bioactive Peptides via Non-Natural,
Sequence-Specific Peptidomimetic Oligomers," Current Opinion in Chemical Biology,
vol. 6, no. 6, p. 872–877, 2002.
R. J. Simon, R. S. Kania, R. N. Zuckermann, V. D. Huebner, D. A. Jewell, S. Banville, S.
Ng, L. Wang, S. Rosenberg and C. K. Marlowe, "Peptoids: a Modular Approach to Drug
Discovery," Proceedings of the National Academy of Sciences, vol. 89, no. 20, p. 9367–
9371 , 1992 .
M. Hagihara, N. J. Anthony, T. J. Stout, J. Clardy and S. L. V. Schreiber, "Polypeptides:
an Alternative Peptide Backbone," Journal of the American Chemical Society, vol. 114,
no. 16, p. 6568–6570, 1992.
K. Burgess, H. Shin and D. S. Linthicum, "Solid-Phase Syntheses Of Unnatural
Biopolymers Containing Repeating Urea Units," Angewandte Chemie International
Edition in English Angew, vol. 34, no. 8, pp. 907-909, 1995.
A. B. Smith, D. A. Favor, P. A. Sprengeler, M. C. Guzman, P. J. Carroll, G. T. Furst and
R. Hirschmann, "Molecular Modeling, Synthesis, and Structures of N-Methylated 3,5Linked Pyrrolin-4-Ones toward the Creation of a Privileged Nonpeptide Scaffold,"
Bioorganic & Medicinal Chemistry, vol. 7, no. 1, pp. 9-22, 1999.
D. H. Appella, L. A. Christianson, I. L. Karle, D. R. Powell and S. H. Gellman, "β-Peptide
Foldamers: Robust Helix Formation In a New Family of β-Amino Acid Oligomers,"
Journal of the American Chemical Society, vol. 118, no. 51, p. 13071–13072, 1996.
S. Hanessian, X. Luo and R. Schaum, "Synthesis And Folding Preferences of γ-Amino
Acid Oligopeptides: Stereochemical Control in the Formation of a Reverse Turn and a
Helix," Tetrahedron Letters, vol. 40, no. 27, p. 4925–4929, 1999.
C. W. Wu, T. J. Sanborn, R. N. Zuckermann and A. E. Barron, "Peptoid Oligomers With
α-Chiral, Aromatic Side Chains: Effects of Chain Length on Secondary Structure,"
Journal of the American Chemical Society, vol. 123, no. 13, p. 2958–2963, 2001.

[2]
[3]

[4]
[5]
[6]

[7]
[8]
[9]

43

[10] S. H. Gellman, "Foldamers: A Manifesto," Accounts of Chemical Research, vol. 31, no.
4, p. 173–180, 1998.
[11] J. R. Stringer, J. A. Crapster, I. A. Guzei and B. H. E., "Construction of Peptoids with All
Trans-Amide Backbones and Peptoid Reverse Turns via the Tactical Incorporation of NAryl Side Chains Capable of Hydrogen Bonding," J. Org. Chem., vol. 75, p. 6068–6078,
2010.
[12] S. B. Shin, B. Yoo, L. J. Todaro and K. Kirshenbaum, "Cyclic Peptoids," J. Am. Chem.
Soc., vol. 129, p. 3218–3225, 2007.
[13] K. Huang, C. W. Wu, T. J. Sanborn, J. A. Patch, K. Kirshenbaum, R. N. Zuckermann, A.
E. Barron and I. Radhakrishnan, "A Threaded Loop Conformation Adopted by a Family
of Peptoid Nonamers," J. Am. Chem. Soc., vol. 128, p. 1733–1738, 2006.
[14] P. Armand, K. Kirshenbaum, A. Falicov, R. L. Dunbrack Jr, K. A. Dill, R. N.
Zuckermann and F. E. Cohen, "Chiral N-Substituted Glycines Can Form Stable Helical
Conformations," Fold. Des. , vol. 2, p. 369–375, 1997.
[15] K. Kirshenbaum, A. E. Barron, R. A. Goldsmith, P. Armand, E. K. Bradley, K. T. V.
Truong, K. A. Dill, F. E. Cohen and R. N. Zuckermann, "Sequence-Specific Polypeptoids:
A Diverse Family of Heteropolymers with Stable Secondary Structure," Proceedings of
the National Academy of Sciences , vol. 95, no. 8, p. 4303–4308, 1998.
[16] P. Armand, K. Kirshenbaum, R. A. Goldsmith, S. Farr-Jones, A. E. Barron, K. T. V.
Truong, K. A. Dill, D. F. Mierke, F. E. Cohen, R. N. Zuckermann and E. K. Bradley,
"NMR Determination of the Major Solution Conformation of a Peptoid Pentamer with
Chiral Side Chains," Proceedings of the National Academy of Sciences, vol. 95, no. 8, p.
4309–4314, 1998.
[17] C. W. Wu, T. J. Sanborn, K. Huang, R. N. Zuckermann and A. E. Barron, "Peptoid
Oligomers With α-Chiral, Aromatic Side Chains: Sequence Requirements for the
Formation of Stable Peptoid Helices," J. Am. Chem. Soc., vol. 123, no. 28, p. 6778–6784,
2001.
[18] T. J. Sanborn, C. W. Wu, R. N. Zuckermann and A. E. Barron, "Extreme Stability of
Helices Formed by Water-Soluble Poly-N-Substituted Glycines (Polypeptoids) with α Chiral Side Chains," Biopolymers, vol. 63, no. 1, pp. 12-20, 2001.
[19] H. Murnen, A. Rosales, J. Jaworski, R. Segalman and R. Zuckermann, "Hierarchical selfassembly of a biomimetic diblock copolypeptoid into homochiral superhelices," J. Am.
Chem. Soc., vol. 132, p. 16112–16119, 2010.
[20] J. Nam, J. Johnson and J. A. S. Lannutti, "Modulation Of Embryonic Mesenchymal
Progenitor Cell Differentiation Via Control Over Pure Mechanical Modulus In
Electrospun Nanofibers," Acta Biomater., vol. 7, p. 1516–1524, 2001.
[21] X. Chen, K. Ding and N. Ayres, "Investigation Into Fiber Formation In N-Alkyl Urea
Peptoid Oligomers And The Synthesis Of A Water-Soluble PEG/N-Alkyl Urea Peptoid
Oligomer Conjugate," Polym. Chem. , vol. 2, p. 2635–2642, 2011.
[22] B. Sanii, R. Kudirka, A. Cho, N. Venkateswaran, G. K. Olivier, A. M. Olson, H. Tran, R.
M. Harada, L. Tan and R. N. Zuckermann, "Shaken, Not Stirred: Collapsing a Peptoid
Monolayer To Produce Free-Floating, Stable Nanosheets," Journal of the American
Chemical Society, vol. 133, no. 51, p. 20808–20815, 2011.

44

[23] E. Robertson, A. P. C. Battigelli, R. Mannige, T. Haxton, L. Yun, S. Whitelam and R.
Zuckermann, "Design, Synthesis, Assembly, and Engineering of Peptoid Nanosheets,"
Acc. Chem. Res., vol. 49, no. 3, p. 379–389, 2016.
[24] M. L. Hebert, D. S. Shah, P. Blake, J. P. Turner and S. L. Servoss, "Tunable Peptoid
Microspheres: Effects of Side Chain Chemistry and Sequence," Organic & Biomolecular
Chemistry, vol. 11, no. 27, p. 4459, 2013.
[25] R. N. Zuckermann, J. M. Kerr, S. B. H. Kent and W. H. Moos, "Efficient Method for the
Preparation of Peptoids [Oligo(N-Substituted Glycines)] by Submonomer Solid-Phase
Synthesis," J. Am. Chem. Soc., vol. 114, no. 26, p. 10646–10647, 1992.
[26] K. T. Nam, S. A. Shelby, P. H. Choi, A. B. Marciel, R. Chen, L. Tan, T. K. Chu, R. A.
Mesch, B.-C. Lee, M. D. Connolly, C. Kisielowski and R. N. Zuckermann, "Free-Floating
Ultrathin Two-Dimensional Crystals from Sequence-Specific Peptoid Polymers," Nature
Materials, vol. 9, no. 5, p. 454–460, 2010.
[27] M. L. Waters, "Aromatic Interactions in Model Systems," Current Opinion in Chemical
Biology, vol. 6, no. 6, p. 736–741, 2002.
[28] A. S. Shetty, J. Zhang and J. S. Moore, "Aromatic π-Stacking In Solution as Revealed
through the Aggregation of Phenylacetylene Macrocycles," Journal of the American
Chemical Society, vol. 118, no. 5, p. 1019–1027, 1996.
[29] C. G. Claessens and J. F. Stoddart, "Interactions In Self-Assembly," Journal of Physical
Organic Chemistry, vol. 10, no. 5, p. 254–272, 1997.
[30] M. Hebert, D. Shah, P. Blake and S. Servoss, "Uniform And Robust Peptoid Microsphere
Coatings," Coatings, vol. 3, no. 2, p. 98–107, 2013.
[31] N. Mahmoudi, L. Reed, A. Moix, N. Alshammari, J. Hestekin and S. L. Servoss, "PEGmimetic peptoid reduces protein fouling of polysulfone hollow fibers," Colloids and
Surfaces B: Biointerfaces, vol. 149, pp. 23-29, 2017.
[32] J. A. Patch, K. Kirshenbaum, S. L. Seurynck, R. N. Zuckermann and A. E. Barron,
"Versatile Oligo(N-Substituted) Glycines: The Many Roles Of Peptoids in Drug
Discovery," Pseudo-Peptides in Drug Development, p. 1–31, 2005.
[33] I. Gokce, R. W. Woody, G. Anderluh and J. H. Lakey, "Single Peptide Bonds Exhibit
Poly(Pro)II (“Random Coil”) Circular Dichroism Spectra," Journal of American Chemical
Society, vol. 127, no. 27, pp. 9700-9701, 2005.
[34] Y. Wei, A. Thyparambil and R. Latour, "Protein Helical Structure Determination Using
CD Spectroscopy for Solutions with Strong Background Absorbance from 190-230 nm,"
Biochim Biophys Acta, vol. 1844, no. 12, p. 2331–2337, 2014.
[35] S. Mukherjee, G. Zhou, C. Michel and V. A. Voelz, "Insights into Peptoid Helix Folding
Cooperativity from an Improved Backbone Potential," The Journal of Physical Chemistry,
vol. 119, no. 50, pp. 15407-15417, 2015.
[36] L. J. Weiser and E. E. Santiso, "Molecular modeling studies of peptoid polymers," AIMS
Materials Science, vol. 4, no. 5, pp. 1029-1051, 2017.
[37] M. R. Dreher, A. J. Simnick, K. Fischer, R. J. Smith, A. Patel, M. Schmidt and A.
Chilkoti, "Temperature Triggered Self-Assembly of Polypeptides into Multivalent
Spherical Micelles," Journal of The American Chemical Society, vol. 130, no. 2, pp. 687694, 2008.

45

[38] T. Shimada, S. Lee, F. S. Bates, A. Hotta and M. Tirrell, "Wormlike Micelle Formation in
Peptide-Lipid Conjugates Driven by Secondary Structure Transformation of the
Headgroups†," The Journal of Physical Chemistry, vol. 113, no. 42, pp. 13711-13714,
2009.
[39] K. Kornmueller, B. Lehofer, G. Leitinger, H. Amenitsch and R. Prassl, "Peptide selfassembly into lamellar phases and the formation of lipid-peptide nanostructures," Nano
Research, vol. 11, no. 2, pp. 913-928, 2018.
[40] S. Gudlur, P. Sukhankar, J. Gao, L. A. Avila, Y. Hiromasa, J. Che, T. Iwamoto and J. M.
Tomish, "Peptide Nanovesicles Formed by the Self-Assembly of Branched Amphiphilic
Peptides," PLoS ONE, vol. 7, no. 9, 2012.
[41] S. Vauthey, S. Santoso, H. Gong, N. Watson and S. Zhang, "Molecular self-assembly of
surfactant-like peptides to form nanotubes and nanovesicles," Proceedings of the National
Academy of Sciences of the United States of America, vol. 99, no. 8, pp. 5355-5360, 2002.
[42] J. D. Hartgerink, E. Beniash and S. I. Stupp, "Self-Assembly and Mineralization of
Peptide-Amphiphile Nanofibers," Science, vol. 294, no. 5547, pp. 1684-1688, 2001.
[43] J. D. Hartgerink, J. R. Granja, R. A. Milligan and M. R. Ghadiri, "Self-assembling Peptide
Nanotubes," Journal of The American Chemical Society, vol. 118, no. 1, pp. 43-50, 1996.
[44] L. Adier-Abramovich, P. Marco, Z. A. Arnon, R. C. Creasey, T. C. Michaels, A. Levin,
D. J. Scurr, C. J. Roberts, T. P. Knowles, S. J. Tendler and E. Gazit, "Controlling the
Physical Dimensions of Peptide Nanotubes by Supramolecular Polymer Coassembly,"
ACS NANO, vol. 10, no. 8, pp. 7436-7442, 2016.
[45] Y.-H. Chiao, A. Sengupta, S.-T. Chen, S.-H. Huang, C.-C. Hu, W.-S. Hung, Y. Chang, X.
Qian, S. Wickramasinghe, K.-R. Lee and J.-Y. Lai, "Zwitterion augmented polyamide
membrane for improved forward osmosis performance with significant antifouling
characteristics," Separation and Purification Technology, vol. 212, pp. 316-325, 2019.
[46] M. H. Chiu and E. J. Prenner, "Differential scanning calorimetry: An invaluable tool for a
detailed thermodynamic characterization of macromolecules and their interactions,"
Journal of Pharmacy BioAllied Sciences, vol. 3, no. 1, pp. 39-59, 2011.
[47] D. Giron, "Applications of Thermal Analysis and Coupled Techniques in Pharmaceutical
Industry," Journal of Thermal Analysis and Calorimetry, vol. 68, no. 2, pp. 335-357,
2002.
[48] B. Sauer, W. Kampert, E. N. Blanchard, S. Threefoot and B. Hsiao, "Temperature
modulated DSC studies of melting and recrystallization in polymers exhibiting multiple
endotherms," Polymer, vol. 41, no. 3, pp. 1099-1108, 2000.
[49] V. Maravajhala, N. Dasari, A. Sepuri and S. Joginapalli, "Design and Evaluation of
Niacin Microspheres," Indian Journal of Pharmaceutical Sciences, vol. 71, no. 6, pp. 663669, 2009.
[50] L. Malavolta, M. R. Pinto, J. H. Cuvero and C. R. Nakaie, "Interpretation of the
dissolution of insoluble peptide sequences based on the acid-base properties of the
solvent," Protein Science, vol. 15, no. 6, pp. 1476-1488, 2006.
[51] S. Shin and K. Kirshenbaum, "Conformational Rearrangements by Water-Soluble Peptoid
Foldamers," Organic Letters, vol. 9, no. 24, pp. 5003-5006, 2007.

46

[52] J. Kim, J. Mao and M. Gunner,
"https://www.sciencedirect.com/science/article/pii/S0022283605003311," Journal of
Molecular Biology, vol. 348, pp. 1283-1298, 2005.
[53] D. Bashford, "Macroscopic Electrostatic Models For Protonation States in Proteins,"
Frontiers in Bioscience, vol. 9, pp. 1082-1999, 2004.
[54] J. Dwyer, A. Gittis, D. Karp, E. Lattman, D. Spencer, Stites, W.E. and B. Garcia-Moreno,
"High apparent dielectric constants in the interior of a protein reflect water penetration.,"
Biophysical Journal, vol. 79, no. 3, pp. 1610-1620, 2000.
[55] M. van der Graaf and M. Hemminga, "Conformational Studies on a Peptide Fragment
Representing the RNA-Binding N-terminus of a Viral Coat Protein Using Circular
Dichroism and NMR Spectroscopy," The FEBS Journal, vol. 201, no. 2, pp. 489-494,
1991.
[56] W. Kohn, C. Kay and R. Hodges, "Protein Destabilization by Electrostatic Repulsions in
the Two-Stranded α-Helical Coiled-Coil/Leucine Zipper," Protein Sci , vol. 4, p. 237–
250., 1995.
[57] I. Jelesarov, E. Durr, R. Thoma and H. Bosshard, "Salt Effects on Hydrophobic
Interaction and Charge Screening in the Folding of a Negatively Charged Peptide to a
Coiled Coil (Leucine Zipper)," Biochemistry, vol. 37, p. 7539 –7550, 1998.
[58] M. Hoshino, N. Yumoto, S. Yoshikawa and Y. Goto, "Design And Characterization f the
Anion-Sensitive Coiled-Coil Peptide.," Protein Sci., vol. 6, no. 7, p. 1396–1404, 1997.
[59] H. I. Okur, J. Hladilkova, Rembert, K. B., Y. Cho, J. Heyda, J. Dzubiella, P. S. Cremer
and P. Jungwirth, "Beyond the Hofmeister Series: Ion-Specific Effects on Proteins and
Their Biological Functions," The Journal of Physical Chemistry, vol. 121, no. 9, pp. 19972014, 2017.
[60] A. H. Crevenna, N. Naredi-Rainer, D. C. Lamb, R. Wedlich-soldner and J. Dzubiella,
"Effects of Hofmeister Ions on the α-Helical Structure of Proteins," Biophysical Journal,
vol. 102, no. 4, pp. 907-915, 2012.
[61] Y. Zhang and P. S. Cremer, "Interactions between macromolecules and ions: The
Hofmeister series.," Current Opinion in Chemical Biology, vol. 10, no. 6, pp. 658-663,
2006.

47

4.

Peptoid Microsphere Coatings to Improve Performance in Sandwich ELISA
Microarrays
Jesse L. Roberts,1 German R. Perez Bakovic,1 and Shannon L. Servoss1, *
1

University of Arkansas, Ralph E. Martin Department of Chemical Engineering, 3202 Bell
Engineering Center, 1 University of Arkansas, Fayetteville, AR 72701
*Corresponding Author

Abstract
Enzyme-linked immunosorbent assay (ELISA) microarray performance is limited by low assay
sensitivity and dynamic range. Increasing the surface area for reagent binding can help to
improve performance, but standard techniques such as roughening the surface or adding a
polymer coating lead to increased non-specific fluorescence and do not have reproducibly
improved performance. Another approach to increase surface area is adding a microsphere
coating on the surface. Poly-N-substituted glycine (peptoid) microspheres are ideal for this
application due to low immunogenicity, protease-resistance, and biocompatibility. Peptoids are
polymers with a backbone similar to peptides, but with the side chains appended to nitrogen
rather than the alpha carbon. A variety of side chain chemistries can be incorporated into
peptoids through a solid-phase, sequence-specific synthesis protocol. Here we report the
development of sandwich ELISA microarray on peptoid microsphere coated glass slides. Coating
morphology was evaluated via SEM and efficacy was assessed by ELISA microarray
performance. Peptoid microsphere coated glass slides exhibit an increase in signal intensity and
dynamic range as compared to commercially available microarray slides. These studies show the
potential for peptoid microspheres as coatings for ELISA microarray slides, as well as for use in
other biosensor applications.
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ELISA – enzyme-linked immunosorbent assay
DSS – Disuccinimidyl suberate
BS3 – bis[sulfosuccinimidyl] suberate
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4.1

Introduction
Over the last several decades there have been numerous publications focused on the

development of sensitive, disease-specific assays to assist in therapeutic decisions [76, 77, 78,
79, 80]. Early disease detection decreases economic costs, improves treatment options, and
reduces mortality [6]. Biomarker-based technologies, including enzyme-linked immunosorbent
assay (ELISA) microarray and bead-based immunoassay, offer platforms for sensitive and
specific disease detection [7]. Multiplex bead array assays (MBAA) such as Luminex, xMap [8],
Smartbead UltraPlex [9], and flow cytometry technologies [10] offer promising, high-throughput
methods of detecting cytokines and other analytes in serum and plasma samples. MBAAs make
it possible to perform immunoassays in a multiplexed design to independently and qualitatively
analyze multiple samples at one time. For instance, the xMAP technique utilizes hundreds of
uniquely colored beads, ranging from much larger magnetic beads (6.5 µm) to smaller nonmagnetic beads (~1 µm), created by two different fluorescent dyes to simultaneously identify
multiple analytes [8]. However, a key concern in the viability of MBAAs is the potential for
interference between analyte samples. The antibodies on each bead may cross-react with other
antibodies, cross-species antibodies, and molecules, ultimately reducing the efficacy of the
MBAA techniques and requiring additional testing to ensure no cross-reacting has occurred [11].
ELISA microarray technology has emerged as a strong platform for the analysis of
biomarkers due to its ability to quantify low-abundance proteins in complex biological fluids
over large concentration ranges [12,2]. ELISA microarray eliminates the cross-reactivity that is
commonly seen in MBAAs by focusing on a single analyte at a time. The use of matched highaffinity antibody pairs to target a single antigen results in unmatched sensitivity and specificity.
The miniature scale of the platform allows for cost-effective and efficient parallel screening of
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small sample volumes in a high-throughput manner [12]. The slide chemistry and morphology is
crucial for optimal performance of ELISA microarray, as is evident by the large number of slide
chemistries commercially available [13, 14, 15, 16, 17, 18, 4]. The slides must allow antibodies
to be immobilized in a manner that maintains protein binding affinity while retaining high
binding capacities, high signal-to-noise ratios, and high reproducibility [19]. Additionally, the
high-throughput nature of the platform requires substrates to be robust and retain high levels of
specificity and sensitivity through rigorous processing conditions and prolonged storage periods.
While poly-L-lysine slides have emerged as promising slide chemistry due to strong antibody
attachment via adsorption and high signal-to-noise ratio [20, 21], ELISA microarray
performance can be further improved by increasing the surface area for antibody attachment. In
theory, increasing the surface area for antibody attachment should enhance the microarray results
by providing more sites of attachment to increase signal intensity and the dynamic range.
Polymer-based surfaces that increase surface area such as polyacrylamide [5, 22], agarose [23],
and nitrocellulose [24, 25, 26, 27, 28] suffer from low signal-to-noise ratios due to absorption of
protein in the porous coating [20, 21].
Poly-N-substituted glycines (peptoids) are promising as coatings for microarray slides
due to their low immunogenicity, ease of synthesis, variety of available side chain chemistries,
and the ability to form supramolecular structures that can increase surface area [29]. Peptoids are
bioinspired, peptidomimetic polymers with a backbone structure closely resembling that of
peptides, but with the side chains appended to the amide groups rather than the alpha-carbons.
This structural modification prevents proteolytic degradation, making peptoids attractive as
biocompatible materials. However, this modification also removes the presence of backbone
amide hydrogens, which are critical for the formation of the hydrogen bond linkages that
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stabilize beta sheets and helices in peptides. Introduction of steric hindrance through side chain
chemistry allows for the formation of secondary structures including turns [30, 31], loops [32],
and helices [33, 34, 35, 36, 37], as well as supramolecular assemblies such as superhelices [38],
nanosheets [39], nanotubes [40], and microspheres [41].
Our lab has previously shown that partially water-soluble, helical peptoids self-assemble
into microspheres [37] and can form uniform surface coatings [44]. The peptoid sequence,
referred to as P3 (Figure 4.1), includes chiral, aromatic side chains on two faces of the helix to
induce the formation of helical secondary structure [41]. The third face of the helix, which offers
considerable flexibility of design, contains methoxy and amine groups to increase water
solubility. The amine groups enable covalent linkage to and electrostatic interactions with the
slide surface. The secondary structure of P3 was determined by circular dichroism, which
confirms polyproline type-I-like secondary structure [35].

Figure 4.1 Peptoid structure for the P3 sequence.
In this study, we report the development of peptoid microsphere coated glass substrates for
use in sandwich ELISA microarray. The morphology and uniformity of the coatings was
evaluated by SEM and the coating efficacy was analyzed by ELISA microarray with known
antibody pairs. The peptoid microsphere coated surfaces were found to exhibit higher signal
intensity and dynamic range as compared to commercially available microarray slides.
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4.2
4.2.1

Materials and Methods
Materials
4-methoxybenzylamine and (S)-methylbenzylamine were purchased from Acros

Organics (Pittsburgh, PA). tert-butyl N-(4-aminobutyl) carbamate was purchased from
CNH Technologies Inc. (Woburn, MA). MBHA rink amide resin was purchased from
NovaBiochem (Gibbstown, NJ). Piperidine was purchased from Sigma-Aldrich (St.
Louis, MO). Test grade silicon wafers were purchased from University Wafer (South
Boston, MA). Poly-L-lysine and ultra clean glass microarray slides were purchased from
Thermo Scientific (Pittsburgh, PA). Disuccinimidyl suberate (DSS) and
bis[sulfosuccinimidyl] suberate (BS3 ) were purchased from Pierce (Rockford, IL, USA).
Purified antibodies and antigens were purchased from R&D Systems (Minneapolis, MN,
USA). Blocking solution containing 10 mg/ml casein in phosphate-buffered saline, pH
7.2 (PBS) was purchased from Bio Rad Laboratories (Hercules, CA, USA). Tyramide
Signal Amplification (TSA) system, including streptavidin-conjugated horseradish
peroxidase, amplification diluent, and biotinyl tyramide, was purchased from Perkin
Elmer (Wellesley, MA, USA). Alexa647-conjugated streptavidin was purchased from
Invitrogen Life Technologies (Gaithersburg, MD). All other reagents were purchased
from VWR (Radnor, PA). Chemicals were used without further modifications unless
otherwise specified.
4.2.2

Peptoid Synthesis
Peptoids were synthesized via the submonomer solid-phase method on rink amide

resin, as previously described [42]. Briefly, the resin was swelled with
dimethylformamide (DMF) and the Fmoc protecting group was removed using a 20%
solution of piperidine in DMF. The resin-bound secondary amine was acylated with 0.4
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M bromoacetic acid in DMF in the presence of N,N’-diisopropyl carbodiimide. Amine
submonomers were incorporated via an SN2 nucleophilic substitution reaction with
primary amine in DMF. The two-step bromoacetylation and nucleophilic substitution
cycle was repeated until all desired side chains were incorporated. The peptoid was
cleaved from the resin using a mixture of 95% trifluoroacetic acid (TFA), 2.5% water,
and 2.5% triisopropylsilane, and the acid was removed using a Heidolph Laborota 4001
rotary evaporator (Elk Grove Village, IL). The peptoid was lyophilized to a powder using
a Labconco lyophilizer (Kansas City, MO) and diluted to a concentration of ~3 mg/ml in
a 50:50 acetonitrile-water solution.
4.2.3

Peptoid Purification
Peptoids were purified using a Waters Delta 600 preparative high-performance

liquid chromatography (HPLC) instrument (Milford, MA) with a Duragel G C18 150 ×
20 mm column (Peeke Scientific, Novato, CA) and a linear gradient of 35-95% solvent B
(acetonitrile, 5% water, 0.1% TFA) in A (water, 5% acetonitrile, 0.1% TFA) over 60
minutes. Peptoids were confirmed to be >98% pure via analytical HPLC (Waters
Alliance, Milford, MA) with a Duragel G C18 150 × 2.1 mm column (Peeke Scientific)
using a linear gradient of 35 to 95% solvent D (acetonitrile, 0.1% TFA) in C (water, 0.1%
TFA) over 30 minutes. Purified peptoid fractions were lyophilized and stored as a powder
at -20 °C.
4.2.4

Peptoid Characterization
Synthesis of the desired peptoid sequence was confirmed via matrix assisted laser

desorption/ionization time of flight mass spectrometry (MALDI-TOF; Bruker, Billerica,
MA). Secondary structure was confirmed via CD spectrometry using a Jasco J-715
instrument (Easton, MD) at room temperature with a scanning speed of 20 nm/min and a
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path length of 0.1 mm. The peptoid was dissolved in methanol at a concentration of 120
µM. Each spectrum was the average of twenty accumulations.
4.2.5

Peptoid Microsphere Coatings
Peptoid microspheres were prepared by dissolving the peptoid in a 4:1 (v/v)

ethanol/water solution at a concentration of 5 mg/ml, as previously described [41]. Glass
slides (Erie Scientific, Portsmouth, NH) were outlined with an 8 x 2 array pattern using a
Barnstead Thermolyne microarray slide imprinter (Dubuque, IA) to create a hydrophobic
barrier for processing 16 wells per slide. The peptoid solution was applied to the glass
surfaces and allowed to dry at room temperature and 60% relative humidity. Coating
morphologies were visually assessed using a Phillips XL-30 scanning electron
microscope (SEM; FEI, Hillsboro, OR).
4.2.6

Microsphere Surface Density Distribution
Microsphere surface density distribution of the microsphere coatings was

calculated using ImageJ software (National Institute of Health, MD). Noise reduction was
completed with a fast Fourier transform (FFT) band-pass filter normalization, eliminating
low- and high-spatial frequencies and transforming the original SEM images to a twodimensional representation of the frequency. The images were converted to 8-bit
grayscale and binarized adjusting the white and black threshold to optimize particle
contrast with the background. Particle analysis was completed on the adjusted images to
give an area percentage for the microsphere particles.
4.2.7

Microarray Printing
ELISA microarray printing was performed at room temperature and 60% relative

humidity as previously described [20]. Briefly, a GeSiM NanoPlotter 2.1 non-contact
microarray printer with humidity control (Quantum Analytics, Foster City, CA, USA)
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was used to spot the antibodies. Prior to spotting, the microsphere coated surfaces, and in
some cases the poly-L-lyisne slides, were treated with a 0.3 mg/ml solution of the homobifunctional cross-linker BS3 in PBS for 20 minutes to create a reactive site for covalent
attachment of antibodies via the amine groups. After incubation, the slides were rinsed in
nanopure water and dried in a centrifuge. Capture antibodies were suspended in PBS to a
concentration of 0.8 mg/ml and ~400 picoliters per spot were printed 500 μm apart in
quintuplicate on each array. Upon completion, the antibodies were allowed to dry for an
additional hour at 60% relative humidity. The slides were blocked with 10 mg/ml casein
in PBS and processed immediately.
4.2.8

ELISA Microarray
ELISA microarray was performed as previously described [20]. Briefly, all

incubation steps were performed at room temperature in a closed, dark, humid chamber,
with gentle mixing on an orbital shaker (Belly Dancer, Stovall Life Science, Greensboro,
NC). A two-step wash procedure between processing steps was performed by submerging
the slides twice into PBS containing 0.05% Tween-20 (PBS-T). The slides were
incubated with a mixture of antigen standards in 1 mg/ml casein in PBS overnight.
Standard curves were created using a three-fold dilution series of the antigen mix along
with an antigen-free blank for twelve total dilutions. Following a wash cycle, the slides
were incubated with biotinylated detection antibody at 25 ng/ml in 1 mg/ml casein in
PBS. The biotin signal was amplified using the TSA system following manufacturer
instructions, and incubated with 1 μg/ml Alexa647-conjugated streptavidin in PBS-T.
The slides were rinsed twice in PBS-T followed by deionized water.
A GenePix Autoloader 4200AL laser scanner (Molecular Devices, CA) was used
to image the Alexa 647 fluorescence signal. The spot fluorescence intensity from the
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scanned slide images was quantified using GenePix Pro 3.0 software. Standard curves
were created using ProMAT, a software program specifically developed for the analysis
of ELISA microarray data based on a four-parameter logistic curves model [43]. The
values for the lower limits of detection are calculated as the median concentration of the
antigen-free blank plus three standard deviations [45]. In order to provide a value that is
representative of all assays for comparisons, a relative limit of detection value was
calculated using the median value for all assay replicates on each surface, as previously
described [20]. Unless noted otherwise, results shown encompass three replicate
experiments performed using slides that were coated, printed, and processed on
independent occasions.
4.3
4.3.1

Results and Discussion
Coating Characterization
The formation of uniform peptoid microsphere coatings is essential to reduce

variability in ELISA microarray. Coating morphology is directly linked to evaporation
rate, requiring careful monitoring of drying conditions to ensure uniform sphere
distribution and reproducible coatings. One issue observed in the formation of peptoid
coatings is perimetral intensive deposition, often referred to as the “coffee ring effect,” in
which denser coverage is observed at the perimeter of the coatings as compared to the
center. Previous studies have shown that this effect is reduced when samples are
evaporated at a constant contact area, which can be achieved by including surfactant in
the microsphere solution [46]. The addition of Tween-20 to the peptoid microsphere
solution results in improved coating uniformity, lessening perimetral microsphere
deposition and allowing for an even distribution of microspheres on the surface (Figure
4.2). At concentrations >0.1%, Tween-20 disrupts microspheres formation and alters
57

microsphere size distribution (Figure S4.1 in Supplemental Information). Previous work
in our lab has focused on the reproducibility of the coatings, the physical properties of the
microspheres, and their ability to withstand various conditions (pH, ionic strength,
solvents) [36][47]. Using ImageJ particle analysis of SEM images, the average local
microsphere surface density (n=10) on the glass slides was 87% (s=2.59%) covered
(Figure S4.2 in Supplemental Information).

Figure 4.2 Peptoid microsphere coated glass surfaces at (A) 3500x and (B) 1000x
magnifications. Peptoids were dissolved in a 4:1 (v/v) ethanol/water solution at a
concentration of 5 mg/ml. The peptoid solution was applied to the glass surfaces and
allowed to dry at room temperature and 60% relative humidity.
When antibodies were spotted directly on the peptoid microsphere coated slides,
faint fluorescent signals were observed indicating weak adsorption of the antibodies to
the surface. The homobifunctional linker, BS3 , was used to covalently attach the
antibodies to the peptoid microsphere coated slides (Figure 4.3A). ELISA microarray
results were reproducible for the slides with covalently attached antibodies. It should be
noted that antibodies were not covalently attached to the poly-L-lysine surfaces because
both our results (Figure 4.3B) and findings by others [20] show no significant difference
in ELISA microarray performance between adsorbed and covalently attached antibodies.
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Figure 4.3 (A) Images of fluorescence for GFP and HGF on peptoid microsphere
coated glass surfaces with (a) non-covalent treated and (b) BS3 treated covalent
surfaces. (B) Images of fluorescence for GFP and HGF on uncoated poly-L-lysine
slides with (a) non-covalent treated and (b) BS3 treated covalent slides.
4.3.2

Coating Efficacy for ELISA Microarray
The efficacy of the peptoid microsphere coatings was evaluated by ELISA

microarray with four antibody assays (Table 4.1) that were previously shown to have
good assay sensitivity and specificity, as well as low cross-reactivity, in multiplexed
ELISA microarray [3]. The performance of the surfaces was evaluated based on spot
morphology, signal to noise ratio, limit of detection, and standard curve dynamic range.
Signal intensities were evaluated by comparing single concentration assays on peptoid
microsphere coated blocks with poly-L-lysine surfaces. Single point antigen
concentrations correspond to the third dilution of the three-fold standard curve dilution
series (i.e., approximately 11% of the maximal concentration), which has previously been
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shown to provide a strong signal intensity near saturation and in the upper usable range of
the standard curve [3].
Table 4.1 Summary of the results detailing the maximal concentration of antigens, lower
and upper bound, dynamic range concentrations, and single point signal intensities (11%
of the maximal concentration) for the ‘uncoated’ poly-L-lysine surfaces and peptoidbased microsphere coated surfaces antigens for all 4 different assays: CD14 (cluster of
differentiation 14), GFP (green fluorescent protein), HGF (hepatocyte growth factor), and
RANTES (regulated on activation normal T cell expressed and secreted).

Spot morphology is dependent on the characteristics of the surface, and as such
the increased topographical complexity of peptoid microsphere coated surfaces presents
challenges. Although the spot morphology on peptoid microspheres is not as crisp as
those on the two-dimensional poly-L-lysine surfaces (Figure 4.3A), they are greatly
improved over other three-dimensional surfaces [20]. The shape of the spots is still
detected and analyzed by the GenePix software without any issues.
As expected, peptoid microsphere coated surfaces consistently displayed stronger
signal intensities as compared to poly-L-lysine slides (Figure 4.3C and Table 4.1). This
observation is consistent for all assays independent of whether the comparisons are based
on a single concentration point (Figure 4.3C) or over the full standard curve (Figure 4.4).
However, as is the case with other three-dimensional slide surfaces, the peptoid
microsphere coated surface exhibits higher background fluorescence as compared to the
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poly-L-lysine surface (Figure 4.3B). Despite the increased background signal, the signalto-noise ratio for the peptoid microsphere coating is the same as or higher than the polyL-lysine coating (Table 4.1). More specifically, the signal-to-noise ratio is higher on the
peptoid microsphere coated slides for three of the four assays tested. These data support
the hypothesis that the use of peptoid microsphere coatings to increase surface area leads
to improved ELISA microarray properties.

Figure 4.4 Standard curves for HGF on uncoated poly-L-lysine slides and peptoid
microsphere coated surfaces. Results are representative of the trends observed across
all antibody assays (see Figure S3 in Supplemental Information). Data points and
cross-bars represent the means and standard deviations, respectively. The standard
curves encompass data from all three replicate experiments performed using slides
that were coated, printed, and processed on independent occasions.
The limit of detection is defined as the lowest concentration that can be reliably
detected and is a direct assessment of assay sensitivity. Evaluation of surface
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performance is based on previously published methods, where relative limit of detection
below 2 is ‘superior’, between 2 and 4 is ‘normal’, and above 4 is ‘poor’ [20]. Despite the
larger standard deviation observed at low antigen concentration for the peptoid
microsphere coatings, they are rated in the superior category with a score of 0.9 ± 0.5 as
compared to a score of 0.8 ± 0.3 for poly-L-lysine slides in our study. These values are
comparable to published values for commercially available slides including poly-L-lysine
(0.7 ± 0.1), aminosilane (1.3 ± 0.6), aldehyde silane (1.1 ± 0.4), epoxysilane (1.2 ± 0.6),
Slide E (0.8 ± 0.4), and Full Moon (1 ± 0.7) [87].
ProMAT interprets the useful range of the standard curves as that between the
lower limit of detection and upper concentration bound. As the standard curve for HGF in
Figure 4 demonstrates, and Table 1 details for all assays, the dynamic range observed for
the peptoid microsphere coated surfaces is increased as compared to poly-L-lysine
surfaces (2.4 pg/ml for CD14, 17 pg/ml for GFP, 357.5 pg/ml for HGF, and 199.6 pg/ml
for RANTES).
4.4

Conclusion
Disease detection requires high-throughput assessment of multiple proteins within

small sample volumes. The use of ELISA microarray and biosensors for disease detection
will require the development of optimized support surfaces that allow for more generally
applicable and direct immobilization procedures. While high binding affinities are
imperative to prevent antibody loss and ensure robust attachment, the challenge lies in
designing a microarray support that accommodates proteins of varying characteristics and
provides an environment that preserves the active form of the protein. The use of peptoid
microsphere coatings as a novel surface for the improvement of sandwich ELISA
microarray has been evaluated. This peptoid-based, three-dimensional coating offers a
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customizable, robust, biocompatible interface that increases the surface area available for
binding. The efficacy of the coating was assessed in terms of its overall ELISA
microarray performance as compared to commercially available poly-L-lysine surfaces.
The peptoid microsphere coated surfaces allowed for strong covalent antibody attachment
and performed well in terms of spot morphology, signal to noise ratio, limit of detection,
and standard curve dynamic range. The increase in surface area enables higher protein
binding capacities as compared to poly-L-lysine surfaces, and although the peptoid
microsphere coatings displayed higher background fluorescence and coefficients of
variation the signal-to-noise ratios were higher as compared to poly-L-lysine surfaces.
Furthermore, the limits of detection were comparable to the poly-L-lysine surfaces and an
improvement in dynamic range was observed for all assays tested.
The peptoid microsphere coatings provide an exciting new interface for a wide
range of biosensor applications. Results suggest that commonly used biosensor protocols
and procedures can be readily applied to peptoid microsphere coatings, and that the
coatings outperform state-of-the art surfaces such as poly-L-lysine. The robust peptoid
microsphere coated surface provides a versatile platform that can be easily customizable
to allow for various surface chemistries and incorporate different attachment sites. It
offers the benefits that come with an increased surface area for binding, while at the same
time allow for use of familiar chemistries that are established for both protein microarray
and biosensor applications.
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Supplemental Information

Figure S4.1 Effects of Tween-20 on microsphere coatings: A) 0.001%, B) 0.01%, C)
0.1%, and D) 1% by volume.

Figure S4.2 The surface coverage density was calculated using ImageJ particle analysis
of A) SEM images of peptoid microsphere coatings and B) processed 8-bit binary
grayscale image.
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Figure S4.3 Standard curves for all 4 antibody assays (CD14, GFP, HGF, and RANTES)
on ‘uncoated’ poly-L-lysine slides and the peptoid-based microspheres coated glass
surfaces.
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5.

Peptoid Microsphere and Polyelectrolyte Multilayer Fabrication for Cell
Culture Applications

5.1

Introduction
Naturally occurring polymers, specifically proteins and peptides, have beneficial

fundamental features that make them ideal candidates for biomedical applications [1].
However, these proteins and peptides are susceptible to proteolytic degradation and often
have low bioavailability [161, 19]. Researchers are increasingly turning to synthetic
polymers, or peptidomimetic oligomers, that emulate the function of naturally occurring
polymers, but have increased resistance to enzymatic degradation [161, 87]. One class of
peptidomimetic oligomers, peptoids or poly-N-substituted glycines, closely resemble the
structure of peptides with the side chains attached to the backbone amide groups rather
than the alpha-carbon as in peptides [162]. This structural modification creates an achiral
backbone and eliminates the hydrogen bond donors, both of which are necessary for
forming secondary structures. By including chiral, aromatic side chains to the peptoid
sequence a helical secondary structure can be induced. Peptoid synthesis involves using a
solid phase “sub-monomer” method that allows for the precise construction of a diverse
polypeptoid sequence library [163]. Thus, making peptoids an attractive candidate for
biomaterial development and therapeutic applications.
Biomimetics have gained traction for use as artificial extracellular matrix (aECM)
components in tissue engineering. The natural extracellular matrix is a complicated
network of various biomacromolecules that includes proteins, polysaccharides, and
glycoproteins [7]. The goal for these biomimetic materials is to generate scaffolds that
directly mimic the natural tissue’s biomechanical and chemical properties to incite
cellular adhesion, growth, and survival for potential in tissue repair and disease treatment.
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The aECM scaffolds must be three-dimensional to fully mimic the complicated ECM
network [8]. Nevertheless, little is known on the direct effect that the topography and
spatial arrangement of aECM structural features have on stem cell fate.
The layer-by-layer (LbL) formation of polyelectrolyte multilayers (PEMs) utilizes
the ionic attraction between oppositely charged materials to alternate the adsorption of
anionic and cationic polyelectrolytes [9]. The ability to tune the chemical, physical, and
topographical properties of the LbL deposition by altering the pH, ionic strength, number
of layers, and layer thickness makes them ideal candidates for tissue engineering,
biosensors, and drug delivery applications [10]. LbL films can be assembled using
naturally occurring and synthetic polymers, creating a vast library of potential polymers
[11]. For example, heparin is an essential polysaccharide found in the ECM and has been
utilized in LbL depositions for enhanced cellular activity. Heparin is known to regulate
cell proliferation, cellular adhesion, matrix assembly, and would healing [12, 13]. Poly-Llysine (PLL) is a cationic, homopolypeptide consisting of repeated positively charged Llysine residues. PLL solutions are commonly coated on cell culturing substrates to help
enhance cell adherence and cell viability [14]. Therefore, LbL films constructed from
heparin and PLL layers makes an interesting candidate as a bioactive substrate for stem
cell culturing.
Our lab has previously shown that partially water-soluble, helical peptoids selfassemble into microspheres [15] and can form uniform surface coatings [16]. The peptoid
sequence (Figure 1.3) includes chiral, aromatic side chains on two faces of the helix to
induce the formation of helical secondary structure. The third face of the helix offers
customizability, contains methoxy and amine groups to increase water solubility. The
amine groups provide a positive surface charge to the microspheres allowing for
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attachment to glass slides and other adducts. The positive charge can serve as an anchor
for LbL development to build thin films of polymers across the surface of the peptoid
microspheres. The customizability of the microsphere chemistry allows for fine-tuning
based on the desired application.
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Figure 1.3 Structure of P3 peptoid (MW=1919 Da).
In this study, we discuss the addition of heparin and poly-L-lysine LbL films to the
peptoid microspheres for potential applications as an aECM substrate. The morphology
and uniformity of the coatings were evaluated by SEM and 3D Laser Scanning
Microscopy. The chemical composition of the coatings was analyzed by FTIR. The
peptoid microsphere and HEP/PLL coated surfaces were found to be biocompatible and
non-cytotoxic with primary cortical rat astrocytes.
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5.2
5.2.1

Materials and Methods
Materials
(S)-methylbenzylamine and 4-methoxybenzylamine were purchased from Acros

Organics (Pittsburgh, PA). tert-butyl N-(4-aminobutyl)carbamate was purchased from CNH
Technologies Inc. (Woburn, MA). MBHA rink amide resin was purchased from NovaBiochem
(Gibbstown, NJ). Piperidine, N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride
(EDC), and N-hydroxysulfosuccinimide sodium salt (Sulfo-NHS), and poly-L-lysine
hydrobromide (mol wt 30,000-70,000) was purchased from Millipore-Sigma (St. Louis, MO).
Ultra clean glass microarray slides and disuccinimidyl suberate (DSS) were purchased from
Fisher Scientific (Pittsburgh, PA). All other reagents were purchased from VWR (Radnor, PA).
All chemicals were used without further modifications unless otherwise specified.
5.2.2

Peptoid Synthesis, Purification, and Characterization
The peptoid was synthesized following a submonomer, solid-phase method on rink amide

resin at room temperature [163]. The synthesis follows two steps: (1) acylation, which adds an
activated carboxylic acid derivative onto a receptive amine generating the backbone of the
peptoid, and (2) amination, the nucleophilic displacement by a primary or N-terminal secondary
amine (side chain). The Fmoc-protection group was removed from the resin using 20%
piperidine/DMF for 12 minutes creating a resin-bound amine. The resin was acylated with 0.4 M
bromoacetic acid in DMF (4.25 mL) and N,N’-diisopropyl carbodiimide (0.8 mL), mixing for 1
minute. The amine submonomers were added to the resin at a concentration of 1.0 M via a
nucleophilic substitution reaction for a period of 2 minutes. The two-step acylation and
nucleophilic substitution cycle was repeated until the desired sequence was obtained. The resin
was washed with DMF (4 x 5mL) after each step and with dicholoromethane (DCM) (3 x 5 mL)

73

after the last submononer was added. The peptoid was cleaved from the resin using a mixture of
95% trifluoroacetic acid (TFA), 2.5% water, and 2.5% triisopropylsilane for 10 minutes prior to
evaporating the acid off using a Heidolph Laborota 4001 rotating evaporator (Elk Grove Village,
IL).
The peptoid was dissolved in a 3 mg/mL solution of acetonitrile and water. The peptoid
was purified using a Waters Delta 600 preparative high-performance liquid chromatography
(HPLC) instrument (Milford, MA) with a Duragel G C18 150 × 20 mm column (Peeke
Scientific, Novato, CA) and a linear gradient of 35-95% solvent B (acetonitrile, 5% water, 0.1%
TFA) in A (water, 5% acetonitrile, 0.1% TFA), over 60 minutes. Peptoids were confirmed to be
>98% pure via analytical HPLC (Waters Alliance) with a Duragel G C18 150 × 2.1 mm column
(Peeke Scientific) using a linear gradient of 5-95% solvent B (acetonitrile, 0.1% TFA) in A
(water, 0.1% TFA), over 30 minutes. Presence of the desired sequence was confirmed via matrix
assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry (Bruker,
Billerica, MA). Purified peptoid fractions were lyophilized and stored as a powder at -20 °C.
5.2.3

Peptoid Microsphere Coatings
In order to create a covalent binding site on the ultraclean glass slides, they were

pretreated with the homo-bifunctional cross-linker, disuccinimidyl suberate (DSS). The DSS (30
mg) was dissolved in DMF (1 mL) and diluted with HPLC-grade methanol (150 mL) to form a
final concentration of 0.2 mg/mL. The DSS solution was applied to the ultraclean glass slides for
5 minutes at room temperature by dipping the slides in the solution using a slide rack and
incubation chamber. The glass slides were rinsed twice with methanol and dried using a
centrifuge at 500 RPM for 30 seconds. Peptoid microspheres were prepared by dissolving the
peptoid in a 4:1 ethanol/water (v/v) solution at a concentration of 3 mg/mL. The peptoid
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microsphere solution was drop casted onto the DSS treated glass slides using a pipette and
allowed to dry at room temperature and 60% relative humidity for 1 hour. The coating
morphology was characterized using a Phillips XL-30 environmental scanning electron
microscope (SEM; FEI, Hillsboro, OR).
5.2.4

Preparation of Polymeric Multilayers on Peptoid Microspheres
HEP and PLL were used to prepare polymeric multilayers on ultraclean glass slides and

peptoid microsphere coated substrates using the LbL technique. The HEP/PLL multilayers were
deposited on the substrates for a combination of 0.5, 1.0, 3.0, and 3.5 bilayers. The ultraclean
glass substrates were treated with poly(ethylenimine) (PEI) dissolved in HEPES buffer (pH 7.4)
for 15 minutes to provide an anchor, or strongly positive layer on the surface. The positive
surface charge of the peptoid microsphere coatings was utilized in applying the first anionic
heparin layer. Both HEP and PLL polymers were dissolved to 1 mg mL-1 in HEPES buffer (pH
7.4), which was also used as the washing solution. We evaluated layers of HEP/PLL ending in
either HEP or PLL for a combination of 0.5 (HEP only), 1.0, 3.0, and 3.5 bilayers. HEP and PLL
were deposited on the glass or peptoid microsphere substrate by pipetting the polymer solution
onto the substrate and incubating for 5 minutes per layer with a 3-minute wash in HEPES buffer
in between. After the desired number of layers was achieved, the substrates were washed with
HEPES for 5 minutes and centrifuged at 500 RPM for 30 seconds to dry. To promote cellular
adhesion, the PEMs were cross-linked overnight with EDC at 10 mg/mL and Sulfo-NHS at 11
mg/mL dissolved in HEPES buffer. After 24 hours, the samples were washed with HEPES buffer
three times and dried using the centrifuge at 500 RPM for 30 seconds. The PEM samples were
stored at 4°C until needed.
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5.2.5

Coating Morphology and Uniformity
The surface topographies of the peptoid microsphere and HEP/PLL coatings were

investigated using a Keyence VK-X260K 3D laser scanning confocal microscope. This
microscope allows for the three-dimensional analysis of the surface without harming the
samples. The images were taken using a 100x objective lens and a surface map was created by
scanning the surface of our samples.
The morphology of the peptoid microsphere and HEP/PLL surfaces was analyzed using a
Phillips XL-30 scanning electron microscope (SEM; FEI, Hillsboro, OR). The peptoid
microsphere coatings were imaged to ensure successful coating of the microspheres prior to
applying the LbL films. Once fabricated, the peptoid microsphere and HEP/PLL coatings were
analyzed using SEM. The samples were sputter-coated with gold prior to imaging to remove
charged electrons from the material and decrease the signal-to-noise ratio allowing for higher
quality images to be captured.
5.2.6

Astrocyte Culturing
Primary cortical rat astrocytes were previously isolated and expanded from 1-day old

neonatal rats and were cryopreserved for future testing [17]. For use in cell viability studies, the
cryopreserved astrocytes were thawed, plated onto tissue culture treated flasks, and expanded to
desired growth numbers in cell growth media consisting of Dulbecco’s Modified Eagle Medium
F12 Formulation (DMEM/F12) supplemented with 10% fetal bovine serum (FBS). The
astrocytes were incubated at 37 °C, 95% humidity, and 5% CO 2 . Prior to seeding, the peptoid
microsphere, LbL, glass control, and fibronectin controls were prepared and transferred to a 12
well plate for testing. The glass for the control samples was sterilized and prepped by sonicating
the ultraclean glass slides in ethanol for 5 minutes, drying in the oven at 70 °C, and treating with
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UV/ozone for 30 minutes. The positive control sample was prepared by adding 50 µL of a 40 µg/
µL fibronectin in sterile distilled water solution. The expanded astrocytes were detached from
the culture surface using trypsin supplemented with EDTA (0.25%), counted with the
hemocytometer, and seeded on the substrates at a cell density of 1 x 105 cells per sample. The
astrocyte seeded substrates were incubated for 72 hours to facilitate astrocyte attachment and
growth.
5.2.7

Cell Viability Assay
The cell viability was assessed using a Live/Dead® Viability/Cytotoxicity Kit that utilizes

green-fluorescent calcein-AM and red-fluorescent ethidium homodimer-1. After 72 hours of
culturing, the media was removed from the cell cultures and the samples were washed with
Dulbecco’s phosphate-buffered saline (D-PBS). A solution of 2 µM calcein and 4 µM ethidium
homodimer-1 in D-PBS was added to the samples for 30 minutes. The live/dead stains were
removed and the cells were imaged with a fluorescence microscope. The live cells were observed
with a fluorescein isothiocyanate (FITC) filter and the dead cells were observed with a
tetramethylrhodamine isothiocyanate (TRITC) filter. The live and dead images were overlaid and
analyzed using ImageJ software.
5.3
5.3.1

Results and Discussion
Coating Characterization
SEM confirmed the uniformity and morphology of the peptoid microsphere coatings on

the glass surfaces (Figure 5.1). From a previous study, the average local microsphere surface
density (n=10) on the glass slides was 87% (s=2.59%) covered. The LbL films were then
deposited on the peptoid microsphere coated glass slides for 0.5, 1.0, 3.0, and 3.5 bilayers of
heparin and poly-L-lysine. SEM confirmed that the peptoid microsphere morphology was
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maintained and the LbL films were successfully deposited on the microsphere surface. Figure 5.2
shows the SEM images for the peptoid microspheres and 0.5 LbL (Figure 5.2A), 1.0 LbL (5.2B),
3.0 LbL (5.2C), and 3.5 LbL (5.2D). The LbL films are visible on top of the peptoid
microspheres and the overall coating coverage is maintained. The topography of the
microsphere coatings is maintained after HEP/PLL depositions are applied to the top of the
microspheres. These topographical features are from the three-dimensional spherical morphology
that the peptoid microspheres create on the surface of the substrates. Overall, the contact angle
between microspheres is important in creating the topography needed for aECM development.

Figure 5.1 SEM image for peptoid microsphere coatings on a DSS treated
glass slide.
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Figure 5.2 SEM images for peptoid microsphere coatings with (A) 0.5 layer (Heparin only),
(B) 1.0 bilayers (Hep/PLL)1.0 , (C) 3.0 bilayers (Hep/PLL)3.0 , and (D) 3.5 bilayers
(Hep/PLL)3.5 .
Although SEM is useful in generating high-resolution images of object morphology and
spatial arrangements, it is limited to two-dimensional characterization. The Keyence 3D Laser
Scanning Optical Microscope (3D LSM) allows for three-dimensional scans of a sample to better
characterization the surface topography and coating uniformity [18]. The 3D LSM utilizes both
optical and laser settings to analyze the surface and depth of a material. The peptoid microsphere
and HEP/PLL films were imaged with the 3D LSM to provide a surface analysis and 3D height
map of our samples (Figure 5.3). For all of the peptoid microsphere and LbL coatings, the 3D
LSM images confirmed the presence of both microspheres and HEP/PLL films. The peptoid
microsphere and 0.5 LbL (HEP)0.5 (Figure 5.3A) and 3.0 LbL (HEP/PLL)3.0 coatings had the best
surface coverage and were the most uniform. The heat maps for all peptoid microsphere and LbL
coatings displayed an increase in height as compared to the peptoid microspheres alone. Due to
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the low sensitivity of the instrument, the height measurement was inconsistent across
experimental replicates. There was an increase in the height with added layers, but the starting
height measurement varied across samples causing the height values given by the 3D scan to be
inaccurate. Overall, the HEP/PLL films were successfully covered the peptoid microspheres
without eliminating the desired spherical topography that is created by the microsphere coating.
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Figure 5.3 3D Laser Scanning Microscope images for (A) 0.5 layer (Heparin only), (B) 1.0
bilayers (Hep/PLL)1.0 , (C) 3.0 bilayers (Hep/PLL)3.0 , and (D) 3.5 bilayers (Hep/PLL)3.5 .
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5.3.2

Chemical Composition Analysis
Fourier transform infrared (FTIR) spectroscopy reveals information on the molecular

nature of chemical compounds and is useful for the characterization of various biopolymers.
FTIR was used to analyze the presence of specific functional groups on our peptoid microsphere
and HEP/PLL coatings (Figure 5.4). The peptoid sequence is composed of a repetitive peptidelike backbone that includes multiple carboxyl and amine groups. The prominent functional
groups for the peptoid side chains include hydroxyl (-OH) groups on the hydroxybenzylamine
side chains and a primary amine groups (-NH3 +) on the lysine-like side chains. The carboxyl
group from the peptoid backbone had an intense adsorption peak at 1650 cm-1 (Figure 5.4A). The
1650 cm-1 peak was present for all of the peptoid microsphere and HEP/PLL coatings, but as
more bilayers were added the intensity of the peak decreased (Figure 5.4B-D). The number of
bilayers for this study was increased to 6.0 bilayers of HEP/PLL to increase the coating
thickness. For 6.0 bilayers, the intensity of the 1650 cm-1 peak drastically decreased by over
50%. The chemical structure of poly-L-lysine has an abundance of positively charged primary
amines. The broad peak at 3,000-3,500 cm-1 for the 6.0 bilayer sample (Figure 5.4D) indicates
the presence of amine bonds (N-H) found in the poly-L-lysine polymer [19]. The FTIR peaks at
1650-1 and the band at 3,000-3,500-1 confirm the presence of the HEP/PLL films on top of our
peptoid microsphere coatings.
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Figure 5.4 FTIR results for glass slides coated with (A) peptoid microspheres, (B) 0.5 layer
(Heparin only), (C) 1.0 bilayers (Hep/PLL)1 , (D) 6.0 bilayers (Hep/PLL)6 . The inset focused on
the main peaks at 1650 cm-1 are representative of the carbonyl (C=O) bond that is common in the
peptoid and heparin structures.
5.3.3

Cytotoxicity/Viability Assay
Cell viability is determined by the number of live cells on the surface and the overall cell

morphology. Cells that are alive and spread out on the surface are considered to have high cell
viability. Healthy astrocyte cells will begin developing cellular networks with neighboring cells
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[22]. Primary cortical rat astrocytes (passage 6-8) that were isolated from 1-day old neonatal rat
pups were used to assess the toxicity of our peptoid and LbL surfaces. The cells were grown on
laminin coated cell culture flasks to confluency and plated on the substrates at 100,000 cells/cm2 .
The samples consisted of uncoated ultraclean glass and ultraclean glass coated with fibronectin
(positive control), peptoid monomer, peptoid microspheres, peptoid microspheres and 0.5
bilayers (heparin only), peptoid microspheres and 1.0 bilayers (HEP/PLL)1.0 , peptoid
microspheres and 3.0 bilayers (HEP/PLL)3.0 , peptoid microspheres and 3.5 bilayers
(HEP/PLL)3.5 , 0.5 LbL (HEP), and 1.0 LbL (HEP/PLL)1.0 . The cells were grown for 3 days prior
to staining with a Live/Dead® Viability/Cytotoxicity Kit that utilizes green-fluorescent calceinAM to indicate intercellular esterase activity and red-fluorescent ethidium homodimer-1 to
indicate the loss of plasma membrane integrity in dead cells. The ethidium homodimer-1 is a
nucleic acid stain that enters dead cells through the disintegrated membrane, while the calceinAM stains all metabolically active cells [170, 171].
The cytotoxicity of the fabricated surfaces was analyzed using the live/dead stains and
imaging with a fluorescent microscope at 10x magnification. The uncoated glass and glass
coated with fibronectin (+ control), 1.0 LbL (HEP/PLL)1.0 , and 3.0 LbL (HEP/PLL)3.0 (Figure
5.5) were tested in comparison to the peptoid-based surfaces (Figure 5.6). Overall, the only
surfaces to have a cell survival rate of less than 97% were the uncoated glass slide (33%) (Figure
5A), peptoid monomer coating (0%) (Figure 6A), and peptoid microsphere coating (0%) (Figure
6B). The cells did not fully adhere to the plain glass surface and had the poorest cell viability as
compared to the fibronectin (Figure 5B) and HEP/PLL coated glass (Figure 5C-D). Fibronectin
was used as the positive control since it is well studied for promoting cellular adhesion and
proliferation. With the rat astrocytes, the fibronectin surface promoted the best cell adhesion,
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proliferation, and viability. The glass and LbL surfaces had good cell adhesion, but less cells
were observed on the surface and they did not branch out compared to those on the fibronectin
sample. The peptoid monomer (Figure 6A) and microsphere (Figure 6B) coatings facilitated cell
adhesion, but all the cells were dead after XX time. Just a single layer of heparin added to the
peptoid microsphere coating (Figure 6C) resulted in increased cell viability with similar cell
morphology to the fibronectin surface. Similar results were observed for the other peptoid
microsphere and LbL coatings (Figure 6D-F). There was no difference in cytotoxicity and cell
viability between the peptoid microsphere and LbL coatings ending in heparin or poly-L-lysine,
where both showed efficacy in promoting cellular adhesion and expansion.
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Figure 5.5 Fluorescent microscopy images of rat astrocytes stained with a live/dead assay on
(A) ultraclean glass, (B) fibronectin coated glass, (C) 1.0 LbL (HEP/PLL)1.0 , and (D) 3.0 LbL
(HEP/PLL)3.0
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Figure 5.6 Fluorescent microscopy images of rat astrocytes stained with a live/dead assay on
(A) peptoid monomer, (B) peptoid microspheres, (C) peptoid microspheres + 0.5 LbL
(HEP)0.5 , (D) peptoid microspheres + 1.0 LbL (HEP/PLL)1.0 , (E) peptoid microspheres + 3.0
LbL (HEP/PLL)3.0 , and (F) peptoid microspheres + 3.5 LbL (HEP/PLL)3.5 .
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5.4

Conclusion and Future Studies
Novel peptoid microsphere and LbL coatings were successfully fabricated for cell

culturing applications. Peptoid microspheres are suitable anchors for HEP/PLL multilayer
development to build biomaterials that combine the spherical topography of the peptoid and the
biocomposition of the LbL polymers. Results revealed that the LbL films up to 3 bilayers are
able to cover the peptoid microspheres without eliminating the spherical morphology of the
microspheres. This is important because the end-goal of this material as an aECM substrate is to
utilize the topography of the surface features to promote stem cell differentiation into specific
adult cell types. For this, we proved that the novel peptoid and LbL substrates promote cell
adhesion and are not cytotoxic to the astrocytes. Future plans include gaining a better
understanding on the surface roughness, mechanical properties, and ability of the surfaces to
promote stem cell proliferation and differentiation.
5.5
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6.
6.1

Peptoid Interfaces for Stem Cell Culturing
Introduction
The extracellular matrix (ECM) is a network composed of proteins and macromolecules that

physically supports the surrounding cells [1]. The ECM plays a major role in dictating stem cell
fate, primarily due to biochemical, mechanical, and topographical cues [174, 175]. Numerous
studies have demonstrated that cells are directly affected by specific chemical and mechanical
properties of naturally occurring ECM components [4]. These cues induce cellular
communication cascades that influence cell proliferation, differentiation, and apoptosis [5].
Engineering an artificial extracellular matrix that directly mimics the natural ECM is an
extremely difficult but critical task for advancing the tissue engineering field. The aECM must
possess excellent structural integrity and tunability, while also maintaining the bioactivity and
biocompatibility of naturally occurring ECM components to help improve cellular
microenvironments [6]. To date, many of the aECMs used for cell culturing have been limited to
two-dimensional substrates. Since the natural ECM is three-dimensional, these 2-D substrates are
not able to directly mimic the ECM network. Recently, it was determined that changes in the
ECM are detected by cell receptors that can dictate cellular gene expression [7]. These changes
can influence cell survival, shape, mitigation, proliferation, and differentiation [8]. The
topography and spatial arrangement of features on artificial ECM surfaces have shown to guide
stem cell attachment and differentiation into specific adult cell types [9]. In designing a
nanocomposite scaffold that mimics the natural ECM it’s important to combine specific features
from various materials. The scaffold must have compatible biochemical cues that promote
cellular adhesion, while also possessing topographical features that promote cellular proliferation
and differentiation into adult cell types.
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The main goal of this study was to create a three-dimensional, highly customizable substrate
that mimics the natural features of the extracellular matrix to promote and guide stem cell
proliferation and differentiation. The work here shows the development and characterization of
peptoid microsphere and LbL coatings and their ability to enhance cell adhesion, proliferation,
and differentiation.
6.2

Peptoid Substrates and Rat Neural Stem Cell Differentiation
The objective for this study was to determine the efficacy of the P3 peptoid microspheres as

an ECM substrate by elucidating the mechanisms that topography plays on stem cell. We
hypothesize that the topography of our peptoid microsphere surface will directly influence the
differentiation pathway of neural stem cells into adult neurons or astrocyte cell types.
In collaboration with the Borrelli Lab at University of Arkansas Medical Sciences, the
ability of our peptoid microsphere coatings to promote neural stem cell proliferation and
differentiation was investigated by culturing rat neural stem cells (rNSCs) on our surfaces for 18
days. Peptoid microsphere coatings were prepared by dissolving the peptoids in 4:1
ethanol/water (v/v) solution at a concentration of 3 mg/mL. The peptoid solutions were applied
to glass substrates using a pipette and allowed to dry at room temperature and 60% relative
humidity for 1 hour. All materials were sterilized with 70% ethanol/water solution or autoclaved
prior to making the peptoid microsphere coatings Since the peptoid is dissolved in ethanol/water,
the peptoid coatings were sterilized using UV treatment for 10 minutes prior to culturing cells.
Three different peptoid microsphere concentrations (1x, 2x, and 3x), or microsphere densities,
were studied by altering the volume of microsphere solution applied to the glass to form the
coatings (Figure 6.1).
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The rNSCs were cultured to confluency prior to plating on the peptoid microsphere
surfaces for differentiation. After 18 days of differentiation, the cells were fixed with
paraformaldehyde and stained with β-tubulin for neurons and glial fibrillary acidic protein
(GFAP) for glial cells. The slides were analyzed with a fluorescent microscope and the results
displayed excellent cell viability and differentiation to primarily adult neurons (70-80%) versus
glial cells (20-30%) (Figure 6.2). We believe that the topography of our peptoid microspheres
plays a role in dictating stem cell differentiation fate.

Figure 6.1 3D Laser Scanning Microscopy images of the peptoid microspheres coated at 1X,
2X, and 3X concentrations for experiments with rat neural stem cell differentiation.

Figure 6.2 Day 18 of rat neural stem cell differentiation on peptoid microsphere coatings
shown by (A) phase contrast microscopy, (B) beta-tubulin stain, and (C) GFAP stain
fluorescent microscopy (Borrelli Lab).
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To determine whether microsphere morphology played a role in rNSC differentiation, we
comparatively cultured the cells on the peptoid monomer coating for 18 days. The peptoid
monomer is the same P3 12mer sequence, but without forming microspheres. The monomer was
coated on glass slides by dissolving the peptoid in 100% methanol at a concentration of 5
mg/mL. The peptoid monomer solution was pipetted onto the glass slides and allowed to dry for
1 hour at room temperature. The presence of the peptoid monomer on the slides was confirmed
by using x-ray photoelectron spectroscopy (XPS) indicated by pi-pi bonds present on the surface
of the coating (Figure 6.3). These pi-pi bond represent the aromatic groups of the methoxybenzylamine and (S)-methylbenzylamine side chains present in the peptoid sequence. The rNSCs
were grown to confluency and plated on the peptoid monomer surface and a laminin control
surface for differentiation. At days 3, 11, 13, and 18 the surfaces were imaged using a confocal
light microscope (Figure 6.4). The stem cells adhered to the peptoid monomer died by day 11
and no proliferation or differentiation was visually seen (Figure 6.4B). The cells on the laminin
surface showed excellent cell viability and proliferated extensively over the 18 days (Figure
6.4A). From this study we concluded that the spherical morphology and surface topography of
the peptoid microspheres plays a major role in neural stem cell proliferation and differentiation.
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Figure 6.3 XPS analysis of peptoid monomer coatings on ultraclean glass slides.

Figure 6.4 Phase contrast microscopy of rat neural stem cell differentiation on (A) Laminin
control and (B) peptoid monomer coated glass slide after 3, 11, 13, and 18 days (Borrelli Lab).
6.3

Peptoid Microsphere and PEM Coatings
The objective of this study was to combine the topography of the peptoid microsphere

coatings with naturally occurring polymeric depositions in the form of PEMs. It was expected
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that the PEMs would utilize the positive surface charge of the peptoid microspheres to create thin
films across the top of the surface. Our work described here focused on the development of
peptoid microsphere coatings that incorporate heparin and collagen or heparin and poly-L-lysine
multilayered films. We determined that by adding 3-6 bilayers of heparin/collagen or
heparin/poly(L-lysine) the films are thin enough to completely cover the microspheres, but the
spherical morphology was still present. The layer-by-layer application method was tested and we
determined that drop-coating (previous chapter), dip-coating, and spin-coating all created
uniform PEM films on the peptoid microsphere surface. Schwann cells and bone-marrow derived
human mesenchymal stem cells (hMSCs) were cultured on the newly developed substrates to test
their efficacy in promoting cell adhesion and proliferation.
6.3.1

Dip-Coating Fabrication of PEM Films
Utilizing the positive surface charge of the peptoid microspheres and a previously

established layer-by-layer method [10], we are able to fabricate heparin/poly(L-lysine)
(HEP/PLL) and heparin/collagen (HEP/COL) thin films across the top of our microspheres.
Peptoid microsphere coatings were made following the previously described method at a
concentration of 3 mg/mL on ultraclean glass slides. All polymers (heparin, poly(L-lysine), and
collagen) were held at a constant concentration of 1 mg/mL in PBS, except the type-1-collagen
must be dissolved in an acetate buffer. The peptoid microsphere coated glass slide was dipped in
the polymer solution for 5 minutes followed by a wash step in PBS for 3 minutes. This was
repeated for each individual polymer layer until samples with a single layer of heparin (sample
0.5), a single bilayer (sample 1.0), and 6 bilayers (sample 6.0) were reached. To determine the
efficiency of our coating method we visually analyzed the sample using SEM. The results
showed that the peptoid microspheres formed uniform coatings alone (Figure 6.5A) and a single
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layer of heparin (Figure 6.5B) added successfully to the peptoid microspheres. However, the 6
bilayers of heparin/poly(L-lysine) formed feather-like appendages that extended across the
surface (Figure 6.5C). The peptoid microspheres were present underneath 6 bilayers confirmed
by the cross-sectional SEM (Figure 6.5D), but little microsphere topography was preserved due
to the increased PEM thickness. The characterization process was repeated for the peptoid
microsphere and HEP/COL PEM coatings as well.

Figure 6.5 SEM images of (A) peptoid microspheres, (B) peptoid microspheres + 0.5
bilayers (Hep)0.5 , (C) peptoid microspheres + 6.0 bilayers (Hep/PLL)6.0 , and (D) cross section
of peptoid microspheres + 6.0 bilayers (Hep/PLL)6.0 .
6.3.2

Peptoid Microspheres + HEP/COL Coatings
PEM films of heparin/collagen were prepared on glass substrates (positive control) and

across the peptoid microsphere coatings by following the LbL method previously mentioned.
Both samples consisted of 6 bilayers of heparin and collagen. Schwann cells and hMSCs were
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cultured on the LbL (HEP/COL)6.0 and peptoid microspheres + LbL (HEP/COL)6.0 , surfaces for 3
days to determine the efficacy of the newly developed substrates for cell culturing. After day 3,
the cells were fixed using paraformaldehyde and stained with Hoescht for the cell nuclei (blue)
and Actin Red (red) for the cytoskeleton. Using ImageJ, the representative fluorescent
microscope images of the Schwann cells and hMSCs were overlaid to display both cell nuclei
and cytoskeleton directly. These images showed that the Schwann cells adhered to both surfaces
and expanded (Figure 6.6). Both surfaces promoted excellent hMSC adhesion and expansion,
while also enhanced cell proliferation (Figure 6.7). The hMSCs also displayed actin fiber
filaments for both surfaces indicating healthy cellular behaviour. Actin filaments are a part of the
MSCs cytoskeleton and has a major role in the mechanical properties of the cells by anchoring to
the nucleus and holding it in place [11]. These studies provide necessary data to suggest further
investigating the potential of peptoid microspheres and PEM films as aECM substrates.

Figure 6.6 Study of morphology and extension of Schwann cells on (A) (HEP/COL)6 and (B)
peptoid microspheres + (HEP/COL)6 surfaces. Representative fluorescence microscopic
overlay images of Schwann Cells nuclei and actin labeled with Hoescht (blue) and Actin Red
(red) after 3 days of culture.
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Figure 6.7 Study of morphology and extension of human mesenchymal stem cells (hMSCs)
on (A) (HEP/COL)6 and (B) peptoid microspheres + (HEP/COL)6 surfaces. Representative
fluorescence microscopic overlay images of MSC nuclei labeled with Hoescht (blue) and
Actin Red (red), respectively, after 3 days of culture.
6.3.3

Peptoid Microspheres + HEP/PLL Coatings
PEM films of heparin/poly-L-lysine were prepared on glass substrates (positive control)

and across the peptoid microsphere coatings by following the LbL method previously mentioned
(Figure 6.5). Both samples consisted of 6 bilayers of heparin and PLL. hMSCs were cultured on
the 6.0 LbL (HEP/PLL)6.0 and peptoid microspheres + 6.0 LbL (HEP/PLL)6.0 , surfaces for 3 days
to determine the efficacy of the newly developed substrates for cell culturing. After day 3, the
cells were fixed using paraformaldehyde and stained with Hoescht for the cell nuclei (blue) and
Actin Red (red) for the cytoskeleton. Optical microscopy showed the cells adhered to the glass
control, peptoid microspheres, peptoid microspheres and 0.5 LbL (HEP)0.5 , and peptoid
microspheres and 6.0 LbL (HEP/PLL)6.0 coatings after 1 day (Figure 6.8). The cells on the
peptoid microsphere samples were difficult to see using the inverted microscope due to the
opaqueness of the coatings. The darker spots on the images represent the hMSCs (Figure 6.8BD). Using ImageJ, the representative fluorescent microscope images of the hMSCs were overlaid
to display both cell nuclei and cytoskeleton directly (Figure 6.9) The hMSCs grew extensively
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on the glass control substrate indicated by the increased number and morphology of the cells on
the surface (Figure 6.9A). The peptoid microsphere coatings had issues with background
fluorescence, but the stained cells adhered to all of the coatings. The morphology of the cells on
the peptoid and LbL coatings differed from the glass control in that the cells never spread out
and stayed in a spheroid morphology (Figure 6.9C-D).

Figure 6.8 Light optical microscope images of human mesenchymal stem cells after 1 day on
(A) Glass substrate (B) peptoid microspheres (C) peptoid microspheres and 0.5 LbL (HEP)0.5 ,
and (D) peptoid microspheres and 6.0 LbL (HEP/PLL)6.0 .
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Figure 6.9 Study of morphology and extension of human mesenchymal stem cells (hMSCs)
on (A) Glass substrate (B) peptoid microspheres (C) peptoid microspheres and 0.5 LbL
(HEP)0.5 , and (D) peptoid microspheres and 6.0 LbL (HEP/PLL)6.0 . Representative
fluorescence microscopic overlay images of MSC nuclei labeled with Hoescht (blue) and
Actin Red (red), respectively, after 3 days of culture.
6.4

Peptoid Monomer and Microspheres in Solution
The goal of this study was to determine the effect that peptoid concentration had on hMSC

growth. To do so, we investigated the cell growth by adding differing concentrations of peptoid
monomer and microspheres directly to the cell media instead of forming peptoid coatings (Figure
6.10). In forming the peptoid monomer, the P3 peptoid was dissolved in water and diluted to 1
mg/mL in PBS and 100 µL or 200 µL of the peptoid monomer solution was added to a well
plate. The hMSCs in cell media were added to form a final volume of 1 mL per well. The final
peptoid monomer concentrations were 0.1 mg/mL and 0.2 mg/mL in each of the two wells.
Results showed that peptoid monomer concentration plays a role in hMSC viability as the higher
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concentrated peptoid monomer solution had no cell adherence and growth. The lower
concentration, 0.1 mg/mL (Figure 6.10C), resulted in improved cell viability as compared to the
TCPS control (Figure 6.10A). The peptoid monomer at lower concentrations was proven to be
non-toxic to the MSCs.
The P3 microspheres were formed by dissolving the peptoid in 4:1 ethanol and water at a
concentration of 1 mg/mL. The peptoid microsphere solution was then diluted in dPBS to a
concentration of 0.1 mg/mL and the solution was centrifuged for 10 minutes. The top layer was
pipetted off to remove the ethanol. This was repeated 4 times and set in the hood to allow
residual ethanol to evaporate. The peptoid microsphere solution (100 µL or 200 µL) was added
to the well plate with hMSCs in media to a final volume of 1 mL per well, for a final peptoid
microsphere concentrations of ~0.01 mg/mL and ~0.02 mg/mL. Results showed that both
peptoid microsphere concentrations were below the threshold that prevents MSC from adhering
and extending out (Figure 6.10D-E). Both peptoid microsphere concentrations in solution had
better cell viability than the TCPS control sample. The hMSCs grown on the higher peptoid
microsphere concentration grew in more linear patterns, indicating that the microspheres in the
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media might play a role in cell arrangement (Figure 6.10E).

Figure 6.10 Study of morphology and extension of human mesenchymal stem cells (hMSCs)
on (A) tissue culturing polystyrene (well-plate), (B) 0.2 mg/mL peptoid monomer, and (C) 0.1
mg/mL peptoid monomer (D) 0.01 mg/mL peptoid microspheres, and (E) 0.02 mg/mL
peptoid microspheres in solution. Representative fluorescence microscopic images of MSC
nuclei (blue) and actin (red) labeled with Hoescht and Actin Red, respectively, after 4 days of
culture.
6.5

Spin-Coating Peptoid Microspheres and LbL Films
Spin-coating is a widely used deposition method that can coat substrates uniformly with

relative ease. It involves casting a material onto a spinning substrate, typically with a pipette
[12]. The centrifugal force pushes the liquid outwards coating the entire substrate and allows for
the fast evaporation of solvent. Since spin-coated is an efficient method of coating substrates, we
decided to study its efficacy as a fabrication technique for our peptoid microspheres and LbL
coatings. First, we wanted to see if spin-coating could drastically reduce the drying time and
conditions (e.g. humidity, tween, airflow) that drop-coating peptoid microspheres required. For
each sample, 30 µL of peptoid microsphere solution was pipetted onto a 25mm x 25mm

103

ultraclean glass slide and the solution was spun for 30 seconds at the desired speed. We
investigated two spin-speeds of 500 RPM and 1,000 RPM. The coatings were characterized
using 3D Laser Scanning Optical Microscopy (Figure 6.11). Both spin speeds formed peptoid
microspheres on the surface, but the 1,000 RPM sample pushed the microspheres from the center
due to the increased centrifugal force. This caused a ring-like effect where more microspheres
were present at the edges of the glass slide (Figure 6.11A). The 500 RPM sample had more
uniform coverage on the glass slide than the higher speed. Both samples had more efficient
drying of the ethanol/water solvent mixture than the traditional drop-casting method. By spincoating the peptoid microspheres onto the glass slides we were able to cut down the drying time
from 30 minutes to 30 seconds.
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Figure 6.11 3D Laser Scanning Optical Microscope analysis of peptoid microspheres spincoated onto an ultraclean glass slide at (A) 1,000 RPM (optical + laser) and (B) 500 RPM
(laser only).
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The ability to spin-coat LbL depositions on the microsphere substrates would potentially
reduce synthesis time and create more uniform coatings. In doing so, a spin-coating technique
that involved spinning each polymer at 5,000 RPM for 1 minute followed by a water wash at the
same spin speed for 1 minute was used to form HEP/PLL bilayers. This process is repeated for
each subsequent layer until the desired number of bilayers are formed. Once the bilayers were
formed, the samples were fully dried with nitrogen gas and stored in a sterile environment for
testing. Then, a single layer of heparin (HEP)0.5 , 1 bilayer (HEP/PLL)1.0 , and 3 bilayers
(HEP/PLL)3.0 were spin coated onto the peptoid microsphere substrates. 3D LSM images of the
spin-coated LbL and peptoid microsphere coatings confirmed the presence of the films on the
microspheres (Figure 6.12A-C). It is important that the spin-coating did not disrupt the peptoid
microsphere morphology, since it will be utilized to potential dictate stem cell fate. All three
coating thicknesses successfully preserved the microsphere morphology, while adding thin
bilayers of the PEM films.
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Figure 6.12 3D Laser Optical Microscope analysis of heparin/poly-L-lysine bilayers spincoated on the peptoid microsphere coated glass slides. The samples were prepared by spincoating (A) heparin only, (B) 1.0 bilayer (Hep/PLL)1.0 ,(C) 3.0 bilayers (Hep/PLL)3.0 on
peptoid microsphere coated glass slides at 5,000 RPM for 1 minute each.
6.6
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7.

Conclusion and Future Directions
The increased presence of biomimetic materials for biomedical applications has led to the

development of more complex technologies. Specifically, there is a need for a material that is
cost-effective, bioavailable, and tunable for various applications. This dissertation demonstrates
the potential of peptoid microspheres as biomaterials for biosensing and cell manufacturing. In
addition, the ability of the microspheres to serve as anchors for PEM development increases their
potential in tissue engineering. The customizability and robustness of the peptoid microsphere
substrate is invaluable as a biomimetic material. The use of peptoids in the form of uniform
peptoid microsphere coatings offers a promising technology in biosensor and aECM substrate
development. This dissertation studied (1) the physical and thermal properties of the peptoid
microspheres along with their robustness in biological environments (Chapter 3), (2) the ability
of peptoid microsphere coatings to enhance ELISA microarray technology (Chapter 4), (3) the
tunability of the peptoid microsphere coatings by adding PEM films (chapter 5), and (4) the
efficacy of peptoid microsphere and LbL coatings in cell culturing applications (Chapter 6). Our
results found that varying peptoid chain length allows for the rational tuning of microsphere size.
It has been demonstrated that the peptoid microsphere coatings are extremely robust for
applications at physiological conditions. Results showed that the use of peptoid microsphere
coatings as a novel surface for ELISA microarrays enhances the limits of detection and signal-tonoise ratios. It has also been proven that LbL technologies can be added to the surface of our
peptoid microsphere coatings to create a more biocompatible and novel interface for cell
culturing. These new materials have been proven to be non-toxic and effective in cell adhesion,
proliferation, and viability.
Future studies for the physical properties of the peptoid microspheres should focus on
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providing valuable insight into the mechanism of formation of the microsphere tertiary structure.
By working with the Center for Integrative Nanotechnologies at Los Alamos National Lab the
packing nature and self-assembly mechanism of the peptoid molecules can be further
investigated. This study should conclude whether the peptoid microspheres are packed or hollow,
the effect of peptoid chain length on packing density, and exactly how the peptoids are arranged
in forming the microspheres. The charge distribution of the spheres could yield insight into the
conformation and arrangement of peptoids in the microspheres. To gather this data, the use of
grazing incidence small-angle x-ray scattering (GISAXS) from a synchrotron would provide the
needed beam flux and q-resolution needed for the size of our peptoid molecules. From this data,
it would be possible to create molecular dynamic simulations to model the formation of
microspheres. These simulations could be carried over to provide an infrastructure to better
model drug loading and delivery along with cell signaling interactions. For the LbL work, the
uniformity of the depositions can be optimized, and the coatings characterized further using zetapotential, XPS, and ellipsometry to provide feedback on the surface charge, chemical
composition, and film thickness, respectively. It would be valuable to further determine the role
that peptoid concentration and morphology plays on stem cells, and whether the peptoid
microspheres influence the fate of stem cell differentiation.
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